Product	EMA	FDA	EN	Other	WHO	Year	Generic	DrugBank ID	ATC	ChEMBL	Indications	Targets	Last Update	
Abemaciclib	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB12001">DB12001</a>	L01EF03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301610">CHEMBL3301610</a>	Advanced Breast Cancer; Metastatic Breast Cancer	CCND2; KRAS; CDK4; CDK6; NRAS; PIK3CA; CDKN2A; ESR1; BRAF; SMARCA4; CCND3; ERBB2; CCND1; PGR; TP53; ESR2	2024-02-07	
Abiraterone	Y	Y	N		Y	2011	Y	<a href="https://go.drugbank.com/drugs/DB05812">DB05812</a>	L02BX03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL254328">CHEMBL254328</a>	Metastatic Castration Resistant Prostate Cancer	CYP17A1; CHEK2; PTEN; CDK12; TSPYL1; ATM; SRD5A1; SRD5A2; PALB2; SRD5A3; BRIP1; APC; DSE; TP53; YBX1; FANCA; AR	2024-02-07	
Acalabrutinib	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB11703">DB11703</a>	L01EL02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3707348">CHEMBL3707348</a>	Chronic Lymphocytic Leukaemia (CLL); Mantle Cell Lymphoma (MCL); Small Lymphocytic Lymphoma	BTK; TP53	2024-02-07	
Aclarubicin	N	N	N	Japan	N			<a href="https://go.drugbank.com/drugs/DB11617">DB11617</a>	L01DB04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL502620">CHEMBL502620</a>		CSF2; SMN1; TOP2A	2024-02-07	
Adagrasib	N	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB15568">DB15568</a>	L01XX77	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594350">CHEMBL4594350</a>	Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer	KRAS	2024-02-07	
Afatinib	Y	Y	N		Y	2013	N	<a href="https://go.drugbank.com/drugs/DB08916">DB08916</a>	L01EB03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1173655">CHEMBL1173655</a>	Metastatic Non-Small Cell Lung Cancer; Refractory, metastatic squamous cell Non-small cell lung cancer	ERBB2; EGFR; ERBB4; PIK3CA; ROS1; EML4; ERBB3; PTEN; NRG1; BRAF; KRAS; ALK	2024-02-07	
Aflibercept	Y	Y	N		N	2011	N	<a href="https://go.drugbank.com/drugs/DB08885">DB08885</a>	S01LA05; L01XX44	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1742982">CHEMBL1742982</a>	Metastatic Colorectal Cancer (MCRC)	VEGFB; PIGF; PGF; VEGFC; VEGFA	2024-02-07	
Aldesleukin	N	Y	Y		N	1992	N	<a href="https://go.drugbank.com/drugs/DB00041">DB00041</a>	L03AC01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201438">CHEMBL1201438</a>	High Risk Neuroblastoma; Metastatic Melanoma; Metastatic Renal Cell Carcinoma	IL2RB; IL2RA; IL2; IL2RG; CD40; EPCAM	2024-02-07	
Alectinib	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB11363">DB11363</a>	L01ED03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1738797">CHEMBL1738797</a>	Refractory, metastatic Non small cell lung cancer	RET; ALK; ROS1; BRAF; TP53; EML4	2024-02-07	
Alemtuzumab	Y	Y	N		N	2001	N	<a href="https://go.drugbank.com/drugs/DB00087">DB00087</a>	L04AA34	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201587">CHEMBL1201587</a>	B-Cell Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic Leukemia	CD52; TP53; CXCL12	2024-02-07	
Alitretinoin	Y	Y	N		N	1999	N	<a href="https://go.drugbank.com/drugs/DB00523">DB00523</a>	D11AH04; L01XF02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL705">CHEMBL705</a>		CD34; RXRB; RARG; ERBB2; RARB; RXRA; CETP; VDR; CCR2; SFTPA1; RXRG; P2RY2; SERPINE1; EHMT2; CGA; RARA	2024-02-07	
Alpelisib	Y	Y	N		N	2019	N	<a href="https://go.drugbank.com/drugs/DB12015">DB12015</a>	L01EM03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2396661">CHEMBL2396661</a>	Advanced Metastatic Breast Cancer	PIK3C3; PIK3R4; PIK3R3; MAP2K1; PIK3CA; ERBB2; PIK3R1; RB1; SGK1; HRAS; PIK3R5; PIK3R6; ESR1; BRAF; FGFR3; PIK3CG; PTEN; CDK4; PIK3CB; ARID1A; PIK3C2A; PIK3C2B; ESR2; PI4KA; FGFR1; NRAS; MTOR; FGFR2; PIK3CD; PIK3C2G; TP53; PIK3R2	2024-02-07	
Altretamine	N	N	Y		N	1990	N	<a href="https://go.drugbank.com/drugs/DB00488">DB00488</a>	L01XX03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1455">CHEMBL1455</a>	Ovarian Cancer; Ovarian Cancer Stage III	CYP1A2	2024-02-07	
Aminolevulinic Acid	Y	Y	N		N	1999	N	<a href="https://go.drugbank.com/drugs/DB00855">DB00855</a>	L01XD04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL601">CHEMBL601</a>	Basal Cell Carcinoma (BCC); Squamous Cell Carcinoma (SCC)	BCL2	2024-02-07	
Amivantamab	Y	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB16695">DB16695</a>	L01FX18	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297774">CHEMBL4297774</a>	Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer	EGFR; MET	2024-02-07	
Amrubicin	N	N	N	Japan	N	2002		<a href="https://go.drugbank.com/drugs/DB06263">DB06263</a>	L01DB10	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1186894">CHEMBL1186894</a>		TOP2A	2024-02-07	
Amsacrine	N	N	N		N	1987	N	<a href="https://go.drugbank.com/drugs/DB00276">DB00276</a>	L01XX01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL43">CHEMBL43</a>	Leukemia, Acute; Refractory Leukemia	TOP2A; MTOR; ATXN2; CYP1A2; CYP2C19; CYP2C9; BTF3P11; ATAD5; CYP3A4; CYP2D6; HSD17B10; CBX1; DRD1; EHMT2; TOP2B	2024-02-07	
Anastrozole	N	Y	Y		Y	1995	Y	<a href="https://go.drugbank.com/drugs/DB01217">DB01217</a>	L02BG03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1399">CHEMBL1399</a>	Advanced Breast Cancer; Early Breast Cancer; Locally Advanced Breast Cancer (LABC); Metastatic Breast Cancer; Invasive, early Breast Cancer	CYP19A1; KMT2C; ESR1; ESR2; TNFSF11; PGR; TNFRSF11B; IGF2; ERBB2; CYP1B1; MAP4K4; TUBB1; DLG2; CSMD1	2024-02-07	
Apalutamide	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB11901">DB11901</a>	L02BB05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3183409">CHEMBL3183409</a>	Nonmetastatic Prostate Cancer	AR	2024-02-07	
Arsenic Trioxide	Y	Y	N		Y	2018	Y	<a href="https://go.drugbank.com/drugs/DB01169">DB01169</a>	L01XX27	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200978">CHEMBL1200978</a>	Refractory Acute Promyelocytic Leukemia	FAS; SERPINE1; TXNRD2; CCND1; CDKN1A; IKBKB; FLT3; TXNRD1; FGFR1; HSPA4; IL6; EPO; SMO; MYCN; TERT; MAPK3; RARA; BDNF; JUN; BIRC5; MT1A; MAPK1; MAPK10; PML; GSTO1; DNMT1	2024-02-07	
Asciminib	Y	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB12597">DB12597</a>	L01EA06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4208229">CHEMBL4208229</a>	Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase	ABL1	2024-02-07	
Asparaginase	Y	Y	N		Y	1994	N	<a href="https://go.drugbank.com/drugs/DB00023">DB00023</a>	L01XX02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108989">CHEMBL2108989</a>	Acute Lymphoblastic Leukaemias (ALL)	ETV6; GRIA1; NFATC2; GATA3; PNPLA3; CPA2; HLA-DRB1; MTHFR; LPL; PYGL; SOD2; ASNS	2024-02-07	
Atezolizumab	Y	Y	N		N	2016	N	<a href="https://go.drugbank.com/drugs/DB11595">DB11595</a>	L01FF05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3707227">CHEMBL3707227</a>	Metastatic Non-Small Cell Lung Cancer; Small Cell Lung Cancer (SCLC); Triple Negative Breast Cancer (TNBC); Urothelial carcinoma ureter metastatic; Locally advanced Urothelial Carcinoma	BRAF; CD274; STK11; ALK; ARID1A; KRAS; JAK3; HLA-DRA; MDM4; EGFR; PBRM1; CTLA4; FGFR3; CX3CL1; PTEN	2024-02-07	
Avapritinib	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB15233">DB15233</a>	L01EX18	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4204794">CHEMBL4204794</a>	Metastatic Gastrointestinal Stromal Tumor; Unresectable Gastrointestinal stromal tumor	KIT; CBL; FLT3; PDGFRA	2024-02-07	
Avelumab	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB11945">DB11945</a>	L01FF04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3833373">CHEMBL3833373</a>	Locally advanced disease has progressed during or following platinum-containing chemotherapy urothelial carcinoma (UC); Locally advanced disease has progressed within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy urothelial carcinoma (UC); Metastatic Merkel Cell Carcinoma (MCC); Metastatic disease has progressed during or following platinum-containing chemotherapy urothelial carcinoma (UC); Metastatic disease has progressed within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy urothelial carcinoma (UC)	CD274; MLH1; ATM; MSH6	2024-02-07	
Axicabtagene Ciloleucel	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB13915">DB13915</a>	L01XX70	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989989">CHEMBL3989989</a>	Refractory Diffuse large B-cell lymphoma NOS; Refractory High grade B-cell lymphoma Burkitt-like lymphoma; Refractory Primary Mediastinal Large B-Cell Lymphoma; Relapsed Diffuse large B-cell lymphoma NOS; Relapsed High grade B-cell lymphoma Burkitt-like lymphoma; Relapsed Primary Mediastinal Large B-Cell Lymphoma	CD19	2024-02-07	
Axitinib	Y	Y	N		N	2012	N	<a href="https://go.drugbank.com/drugs/DB06626">DB06626</a>	L01EK01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1289926">CHEMBL1289926</a>	Advanced Thyroid cancer	FLT1; PDGFRB; FLT4; KDR; YES1; BRAF; ABL1; PDGFB; VHL; UGT1A7; ABCG2; OR2B11; UGT1A10; UGT1A8; UGT1A9; HIF1A; KIT; PDGFRA	2024-02-07	
Azacitidine	Y	Y	N		N	2004	Y	<a href="https://go.drugbank.com/drugs/DB00928">DB00928</a>	L01BC07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1489">CHEMBL1489</a>	Acute Myeloid Leukemia (AML); Chronic Myelomonocytic Leukemia	TAGLN; ATAD5; IDH1; DNMT1; NFE2L2; TRIT1; SMAD3; TET2; GSTP1; TP53; CDA; AFP; RORC; GGT1; PLAU; ALDH1A1; GATA2; TG; IDH2; NR3C1; HBB; LIF; CD247; AR; ABL1; THPO; DNMT3A; IL11; HTT; MYC; GMNN; FLT3; MGMT	2024-02-07	
BCG Vaccine	Y	Y	N		Y			<a href="https://go.drugbank.com/drugs/DB12768">DB12768</a>	L03AX03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108905">CHEMBL2108905</a>	Non-Invasive Bladder Urothelial Carcinoma; Recurrent Superficial Bladder Cancer; Urothelial Carcinoma Recurrent; Carcinoma in situ of urinary bladder	CSF2; NOS1; SFTPA1; IL15; HLA-B; BAX; TNF; FAS; EIF2AK2; MAPK8; AFP; PIK3CA; CXCL2	2024-02-07	
Belantamab Mafodotin	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB15719">DB15719</a>	L01FX15	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298209">CHEMBL4298209</a>	Relapsed Or Refractory Multiple Myeloma	TUBB2A; TUBB1; TUBA3C; TUBB3; TUBB2B; TUBB4A; TUBA1B; TUBB8; TNFRSF17; TUBB4B; TUBB; TUBA3E; TUBA1A; TUBB6; TUBA1C; TUBA4A	2024-02-07	
Belinostat	N	Y	N		N	2014	N	<a href="https://go.drugbank.com/drugs/DB05015">DB05015</a>	L01XH04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL408513">CHEMBL408513</a>	Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-cell Lymphoma Unspecified	HDAC1; HDAC4; HDAC9; HDAC3; HDAC5; HDAC8; HDAC11; UGT1A1; FBXW7; HDAC2; HDAC6; KMT2A; HDAC10; HDAC7	2024-02-07	
Belotecan	N	N	N	South Korea	N	2003		<a href="https://go.drugbank.com/drugs/DB12459">DB12459</a>	L01CE04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2111084">CHEMBL2111084</a>		TOP1	2024-02-07	
Belzutifan	N	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB15463">DB15463</a>	L01XX74	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4585668">CHEMBL4585668</a>	Advanced Renal Cell Carcinoma	VHL; EPAS1	2024-02-07	
Bendamustine	N	Y	Y		Y	2008	Y	<a href="https://go.drugbank.com/drugs/DB06769">DB06769</a>	L01AA09	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL487253">CHEMBL487253</a>	Chronic Lymphocytic Leukaemia (CLL); Follicular Non-Hodgkin&#39;s Lymphoma Refractory; Refractory Hodgkin Lymphoma; Refractory Mantle Cell Lymphoma; Waldenstrom&#39;s Macroglobulinemia (WM); Recurrent multiple myeloma; Refractory indolent B cell non-hodgkin lymphoma	CD69; ATM; TP53	2024-02-07	
Bevacizumab	Y	Y	N		Y	2004	N	<a href="https://go.drugbank.com/drugs/DB00112">DB00112</a>	S01LA08; L01FG01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201583">CHEMBL1201583</a>	Cervical Cancer Metastatic; Metastatic Colorectal Cancer (MCRC); Metastatic Non-Squamous Non-Small Cell Lung Cancer; Metastatic Renal Cell Carcinoma; Persistent Cervical Cancer; Recurrent Cervical Cancer; Recurrent Glioblastoma; Stage III epithelial ovarian cancer following initial surgical resection; Stage IV epithelial ovarian cancer following initial surgical resection; Fallopian tube cancer following initial surgical resection; Locally advanced nonsquamous non-small cell lung cancer; Primary peritoneal cancer following initial surgical resection; Recurrent Non-Squamous Non-Small Cell Lung Cancer; Recurrent Platinum-Sensitive Epithelial Ovarian Cancer; Recurrent Platinum-resistant Epithelial Ovarian Cancer; Recurrent platinum drug resistant Fallopian tube cancer; Recurrent platinum drug resistant primary peritoneal cancer; Recurrent platinum sensitive primary peritoneal cancer; Recurrent platinum-sensitive fallopian tube cancer; Unresectable Non-Squamous Non-Small-Cell Lung Cancer	EDN1; HRAS; NF1; VEGFA; CXCR4; KRAS; NF2; MTHFR; SHMT1; ANXA11; EGFR; CXCL8; KIT; HSP90AB1; ARID1A; MGAT4A; GC; VEGFB; CCT3; MMP9; ALK; PRKCA; TP53; THBS2; HOXC10; PIK3CA; F2R; EML4; VEGFC; FOXF1; MMP2; GGH; IDH1; BRAF; VHL; RALBP1	2024-02-07	
Bexarotene	Y	Y	N		N	1999	Y	<a href="https://go.drugbank.com/drugs/DB00307">DB00307</a>	L01XF03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1023">CHEMBL1023</a>	Refractory peripheral cutaneous T-cell lymphoma	RXRA; RXRB; MAPK8; KAT2A; RXRG; NR1I2; BLM; NR1H3; USP1	2024-02-07	
Bicalutamide	N	Y	Y		Y	1995	Y	<a href="https://go.drugbank.com/drugs/DB01128">DB01128</a>	L02BB03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL409">CHEMBL409</a>	Stage D2 Prostatic carcinoma	CYP2B6; FST; BAX; CFLAR; AR; KMT2D; VDR; KLK3; CDH1	2024-02-07	
Binimetinib	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB11967">DB11967</a>	L01EE03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3187723">CHEMBL3187723</a>	Metastatic Melanoma; Unresectable Melanoma	MAP2K2; APC; PTEN; MAP2K1; KRAS; BRAF; UGT1A1; NRAS; JAK2; MAP2K3; HRAS; ATM; MAP2K5; MAP2K4; PIK3CA; MAP2K6; MAP2K7; NF1; KIT	2024-02-07	
Bleomycin	N	Y	Y		Y	1973	Y	<a href="https://go.drugbank.com/drugs/DB00290">DB00290</a>	L01DC01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL403664">CHEMBL403664</a>	Cervical Cancers; Head and Neck Carcinoma; Intracranial Germ Cell Tumors; Lymphoma, Hodgkins; Malignant Pleural Effusions; Non-Hodgkin&#39;s Lymphoma (NHL); Ovarian Cancer; Penile Cancer; Testicular Cancer; Vulvar Cancers; Early Kaposi&#39;s sarcoma	IFNG; MAPK8; F2R; PLAU; NFE2L2; SMAD2; BLMH; AFP; WRN; GJA1; CCL17; CTLA4; GSTP1; ADK; GSTM1; BRCA1; LIG1	2024-02-07	
Blinatumomab	Y	Y	N		N	2014	N	<a href="https://go.drugbank.com/drugs/DB09052">DB09052</a>	L01FX07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1742992">CHEMBL1742992</a>	Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory; Relapsed B cell precursor Acute lymphoblastic leukemia	CD19; CD3E; CD3D; ABL1; BCR; CD3G; CD247	2024-02-07	
Bortezomib	Y	Y	N		Y	2003	Y	<a href="https://go.drugbank.com/drugs/DB00188">DB00188</a>	L01XG01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL325041">CHEMBL325041</a>	Mantle Cell Lymphoma (MCL); Multiple Myeloma (MM)	PSMB1; PSMD7; PSMC2; PSMA3; PSME1; PSMB4; PSMD4; PSMC1; PSMD12; PSMD3; BDNF; PSMA7; PSMD14; PSMD10; PSMB6; PSMD8; PRSS3; PSMA4; PSMB10; CAPN1; PSMD10P1; PSMC3; PSMB11; F2; PSME4; PSMD1; PSME2; PSMD9; PSMB2; PSMD13; PLG; PSMB8; PSME2P2; PIPSL; PSMA5; PMAIP1; PSMA2; PSMC4; CTSB; PLAT; F12; ADRM1; PSMB3; PSMC5; PRSS1; AR; PSMF1; PSMA8; CTLA4; XIAP; PSMC3IP; PSME3; BCL2; BCL2L2; PSMD5; CTSL; PSMC1P1; NFE2L2; CCND1; SEM1; PSMB9; PSMD11; FLT3; PSMA1; E2F1; DDIT3; PSMD10P3; PIK3CA; TP53; PRB2; PRSS2; HSPB2; FGFR3; PIK3CG; GATA2; PSMD10P2; PSMD6; NFKB1; PSMC6; PSMD4P1; PSMD2; PSMB7; HSPA4; PSMA6; PSMB5	2024-02-07	
Bosutinib	Y	Y	N		N	2010	N	<a href="https://go.drugbank.com/drugs/DB06616">DB06616</a>	L01EA04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL288441">CHEMBL288441</a>	Refractory, accelerated phase Chronic myelogenous leukemia; Refractory, blast phase Chronic myelogenous leukemia; Refractory, chronic phase Chronic myelogenous leukemia	ABL1; SRC; BRCA2; LYN; CAMK2G; HCK; BRAF; BCR	2024-02-07	
Brentuximab vedotin	Y	Y	N		N	2011	N	<a href="https://go.drugbank.com/drugs/DB08870">DB08870</a>	L01FX05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1742994">CHEMBL1742994</a>	B-large cell anaplastic Lymphoma (Kiel Classification) refractory; Refractory Hodgkin Lymphoma; Post-autologous hematopoietic stem cell transplantation Hodgkin lymphoma	TUBB2A; TUBA3C; TUBA4A; TUBB1; ALK; TNFRSF8; TUBB2B; TUBB4A; TUBA1A; TUBB; TUBB4B; TUBA1B; TUBB6; TUBA3E; TUBB8; TUBB3; TUBA1C	2024-02-07	
Brexucabtagene Autoleucel	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB15699">DB15699</a>	L01XL06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594618">CHEMBL4594618</a>	Refractory Mantle Cell Lymphoma; Relapsed Mantle Cell Lymphoma	CD19	2024-02-07	
Brigatinib	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB12267">DB12267</a>	L01ED04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545311">CHEMBL3545311</a>	Metastatic Non-Small Cell Lung Cancer	ALK; EGFR; FGFR1; ROS1; FLT3; TP53; EML4	2024-02-07	
Buserelin	N	N	Y		N	2017	N	<a href="https://go.drugbank.com/drugs/DB06719">DB06719</a>	L02AE01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110824">CHEMBL2110824</a>	Stage D2 Prostatic carcinoma	GNRHR; IGFBP1	2024-02-07	
Busulfan	Y	Y	N		N	1954	Y	<a href="https://go.drugbank.com/drugs/DB01008">DB01008</a>	L01AB01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL820">CHEMBL820</a>	Essential Thrombocythemia (ET); Polycythemia Vera (PV); Chronic Chronic myelogenous leukemia	GSTM1; GSTA1; BCR; ABL1; CYP2D6; CYP2C9; ADK; GSTP1; ITGAL; CYP2C19; CYP2B6; THPO; CYP3A4; SHBG; GALC; G6PD; CYP1A2; ABCC3	2024-02-07	
Cabazitaxel	Y	Y	N		N	2010	N	<a href="https://go.drugbank.com/drugs/DB06772">DB06772</a>	L01CD04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201748">CHEMBL1201748</a>	Refractory, metastatic hormone-refractory Prostate cancer	TUBA1C; TUBB2B; TUBA3C; TUB; IGF2; TUBB4B; TUBA1A; CYP3A4; TUBA4A; TUBB; TUBB1; TUBA1B; TUBB3; TUBB8; TUBB2A; TUBA3E; CYP3A5; ABCB1; TUBB6; TUBB4A	2024-02-07	
Cabozantinib	Y	Y	N		N	2012	N	<a href="https://go.drugbank.com/drugs/DB08875">DB08875</a>	L01EX07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105717">CHEMBL2105717</a>	Advanced Renal Cell Carcinoma; Hepatocellular Carcinoma; Metastatic Clear Cell Renal Cell Carcinoma; Progressive, metastatic Medullary thyroid cancer	MET; RET; KIT; PIK3CA; HRAS; HGF; TEK; FLT3; CTNNB1; ABL1; GNA11; KDR; NRAS; CFLAR; YES1; ROS1	2024-02-07	
Calaspargase Pegol	N	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB14730">DB14730</a>		<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108728">CHEMBL2108728</a>	Acute Lymphoblastic Leukaemias (ALL)	ASRGL1	2024-02-07	
Capecitabine	Y	Y	N		Y	1998	Y	<a href="https://go.drugbank.com/drugs/DB01101">DB01101</a>	L01BC06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1773">CHEMBL1773</a>	Duke&#39;s C Colon cancer; Esophageal Cancers; Hepatobiliary Cancers; Malignant Neoplasm of Stomach; Metastatic Breast Cancer; Metastatic Colorectal Carcinoma; Pancreatic Cancer Metastatic; Refractory Fallopian Tube Carcinoma; Metastatic pancreatic endocrine carcinoma; Refractory Ovarian cancer; Refractory peritoneal cancer; Refractory, metastatic Colorectal carcinoma	SSU72; CYP1A1; NSUN3; ABCG2; DPYD; TP53; REV3L; CES1P1; ADCY2; KRAS; SLC19A1; ABCB1; TYMS; PIK3CA; AREG; CES1; MGAT4A; UGT1A1; CD96; EXO1; ATM; BRAF; PTEN; TYMSOS; UPB1; ADGRG7; SELE; UMPS; CYP19A1; ZMIZ1; SLC22A7; DLG5; ERBB2; PTGS2	2024-02-07	
Capivasertib	N	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB12218">DB12218</a>	L01EX27	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2325741">CHEMBL2325741</a>	Hormone Receptor-positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer	AKT2; PIK3CA; AKT1; AKT3; PTEN; MTOR; TP53	2024-02-07	
Capmatinib	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB11791">DB11791</a>	L01EX17	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3188267">CHEMBL3188267</a>	Metastatic Non-Small Cell Lung Cancer	MET; PTEN	2024-02-07	
Carboplatin	N	Y	Y		Y	1989	Y	<a href="https://go.drugbank.com/drugs/DB00958">DB00958</a>	L01XA02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1351">CHEMBL1351</a>	Advanced Cervical Cancer; Advanced Endometrial Cancer; Advanced Esophageal Cancers; Advanced Head and Neck Cancer; Advanced Melanoma; Advanced Non Small Cell Lung Cancer; Advanced Ovarian Carcinoma; Advanced Sarcoma; Metastatic Breast Cancer; Neuroendocrine Carcinoma of the Skin; Pleural mesothelioma malignant; Refractory Hodgkin Lymphoma; Retinoblastoma; Advanced Bladder cancer; Advanced Small cell lung cancer; Advanced Testicular cancer; Advanced Thymoma; Advanced thymic carcinoma; Refractory Non-Hodgkin&#39;s lymphoma	SERPINA5; SLC31A1; KRAS; MAP3K1; ATP7B; GCLC; DSCAM; MUCL3; HSD17B10; CYP3A5; CDSN; EGFR; GSTP1; MTR; NF2; PSORS1C1; C6orf15; ATP7A; CDKN1A; XRCC1; HCP5; MAD1L1; ACSS2; VDR; VEGFA; PTEN; TP53; TP73; ATAT1; FGFR1; SLC19A1; SLCO1B3; PIK3CA; ERBB2; DOCK8; ETS2; ERCC2; ROS1; GSTT1; NRAS; GPX5; NR1I2; BRCA1; USP1; MTHFR; ABCB1; PPP1R18; FNTB; RRM1; POLK; UGT1A1; BIRC5; HLA-C; CDK2; TNF; ERCC1; ERBB3; TRIM5; KAT2A; APEX1; RNF8; ALDH1A1; OPRM1; EIF4E2; ADAMTSL4-AS1; MAPT; BCL2; BRCA2; SOX10; SERPINC1; GSR; PRRC2A; NRG1; TIGD1; MSH5; RAF1; XYLT2; DDX53; SCN10A; OR4D6	2024-02-07	
Carfilzomib	Y	Y	N		N	2009	N	<a href="https://go.drugbank.com/drugs/DB08889">DB08889</a>	L01XG02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL451887">CHEMBL451887</a>	Refractory Multiple Myeloma; Waldenstrom&#39;s Macroglobulinemia (WM)	PSMD8; PSMA4; PSMD13; PSMB7; PSMB1; PSMB10; PSMC2; PSMB9; PSMA2; PSMA6; PSMC4; NFE2L2; PSMD4; PSMB6; PSMB3; PSMB4; PSMB8; PRB2; PSMC5; PSMD6; PSMB5; PSMD7; PSMA7; PSMD12; PSMA1; PSMA5; PSMD14; PSMB11; PSME4; PSMC6; PIPSL; AR; PSMD2; PSMD10P1; PSMF1; PSMA3; PSMD3; PSMD10; PSMD9; PSMD5; SEM1; PSMC3; PSMD4P1; PSMD10P2; PSMC3IP; VEGFA; PSME1; PSMD10P3; PSME2P2; ADRM1; PSMD1; PSME3; PSMC1; PSMA8; PSMB2; PSME2; PSMC1P1; PSMD11; KDR	2024-02-07	
Carmofur	N	N	N	Japan	N			<a href="https://go.drugbank.com/drugs/DB09010">DB09010</a>	L01BC04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL460499">CHEMBL460499</a>		CYP3A4	2024-02-07	
Carmustine	Y	Y	N		N	1977	Y	<a href="https://go.drugbank.com/drugs/DB00262">DB00262</a>	L01AD01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL513">CHEMBL513</a>	Astrocytomas; Brain Stem Gliomas; Ependymomas; Glioblastomas; Medulloblastomas; Mycosis Fungoides (MF); Recurrent Glioblastoma Multiforme; Refractory Hodgkin Lymphoma; Refractory Multiple Myeloma; Tumors Metastatic to Brain; High grade newly diagnosed Glioma; Refractory Non-Hodgkin&#39;s lymphoma	CYP2C9; CYP2D6; CYP3A4; MGMT; GSR; G6PD; PLAU; E2F1; CYP2C19; CYP1A2; ALDH1A1	2024-02-07	
Cemiplimab	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB14707">DB14707</a>	L01FF06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297723">CHEMBL4297723</a>	Metastatic cutaneous squamous cell carcinoma; Locally advanced cutaneous squamous cell carcinoma, and not a candidate for curative surgery or curative radiation	PDCD1; CD274; ROS1; CDK12; ALK; EGFR	2024-02-07	
Ceritinib	Y	Y	N		N	2014	N	<a href="https://go.drugbank.com/drugs/DB09063">DB09063</a>	L01ED02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2403108">CHEMBL2403108</a>	Refractory, locally advanced Non-small cell lung cancer; Refractory, metastatic Non small cell lung cancer	EML4; ALK; ABCB1; NRAS; INSR; IGF1R; NPM1; TP53; TSSK1B; MAP2K1; CYP3A4; ROS1	2024-02-07	
Cetuximab	Y	Y	N		N	2004	N	<a href="https://go.drugbank.com/drugs/DB00002">DB00002</a>	L01FE01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201577">CHEMBL1201577</a>	Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN); Metastatic Colorectal Cancer (MCRC); Metastatic Squamous Cell Carcinoma of the Head and Neck; Recurrent Squamous Cell Carcinoma of the Head or Neck; Regionally Advanced Squamous Cell Carcinoma of the Head and Neck	PTEN; EGFR; KRAS; MAP2K1; HBEGF; NT5E; ERBB3; TGFA; GC; NRAS; PIK3CA; FCGR3A; EREG; NF2; IDH1; HRAS; BAX; EGF; BRAF; CXCL8; NRG3; MGAT4A; SMAD4; NRG2; MET; AREG; CTNNB1; PTP4A3; BTC; TP53; BDNF; ERBB2; VPS37A; NRG1	2024-02-07	
Chlorambucil	N	Y	Y		Y	1957	N	<a href="https://go.drugbank.com/drugs/DB00291">DB00291</a>	L01AA02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL515">CHEMBL515</a>	Chronic Lymphocytic Leukaemia (CLL); Hodgkins Disease (HD); Non-Hodgkin&#39;s Lymphoma (NHL); Waldenstrom&#39;s Macroglobulinemia (WM); Giant follicular lymphoma	CXCL12; BAZ2B; NFKB1; ERBB2; RORC; MGMT; PALB2; GFER; GSTM1; TP53; FANCC	2024-02-07	
Ciltacabtagene Autoleucel	Y	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB16738">DB16738</a>		<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4802263">CHEMBL4802263</a>	Refractory Multiple Myeloma, Relapsed Multiple Myeloma	TNFRSF17	2024-02-07	
Cisplatin	N	Y	Y		Y	1978	Y	<a href="https://go.drugbank.com/drugs/DB00515">DB00515</a>	L01XA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2068237">CHEMBL2068237</a>	Advanced Pancreatic Cancer; Breast Cancer; Cervical Cancers; Esophageal Cancers; Head and Neck Carcinoma; Hepatobiliary Cancers; Hepatoblastomas; Malignant Neoplasm of Stomach; Medulloblastomas; Metastatic Melanoma; Multiple Myeloma (MM); Neuroblastomas; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer Metastatic; Pleural Mesotheliomas; Primary Central Nervous System Lymphoma (PCNSL); Recurrent Endometrial Cancer; Refractory Hodgkin Lymphoma; Sarcoma, Osteogenic; Small Cell Lung Cancer (SCLC); Thymic Cancer; Advanced Bladder cancer; Metastatic Anal cancer; Metastatic Endometrial cancer; Metastatic Penile cancer; Metastatic Testicular cancer; Refractory Non-Hodgkin&#39;s lymphoma	BARD1; KRAS; TP73; BLMH; NR1I2; MIR21; ATR; GABPA; BIRC7; BAX; CYBA; MTHFD1; ESR1; APEX1; G6PD; GSTT1; SLC19A1; ACYP2; KDM4E; RECQL; ATP7B; MTR; MAPT; SLC22A1; ADH1C; TP53; POLR1G; GALNT18; LIF; ALK; FGFR1; FAS; BCL2; HEXB; ERCC6; RRM1; MGMT; GSTP1; NRG1; HMGB1; IL6; NFE2L2; TGM2; ALOX15; IFNG; PPP1R13L; ATM; SLC31A1; OTOS; BRCA2; KAT2A; PALB2; CASP3; RB1; EHMT2; ACTL6A; H2AC25; HTR4; TPMT; IDH1; DNMT1; XRCC3; CGA; ABCC4; NTRK2; MT1H; PLAU; GALNT14; PTEN; BIRC5; HPGD; RGS4; FANCC; RAD51C; PIK3CA; ABCC1; CBX1; TERC; FASLG; MTHFR; CCND1; CDC25C; HSD17B10; GCLC; FANCA; CLCN6; LRP2; FXN; STAT1; GADD45A; HSPA8; PRL; ABCC5; RARS1; HSPA4; XRCC5; MLLT3; TOP1; XPC; DRAM1; ALDH1A1; MUTYH; DFFB; TMEM43; GRP; ATRX; ACSS2; E2F1; KRT20; AQP9; MYCN; NRAS; SMARCA4; OSGEP; MDH2; GCLM; AURKA; CHEK1; ANPEP; GSTM4; ERCC4; GNAS; CDK12; NF2; TYMS; GPX5; MYC; UBE2I; CSNK2A3; MT1F; BRCA1; MECP2; RAF1; XIAP; MAP3K1; CDH17; XRCC1; EGFR; ERCC2; MSH2; DCBLD1; CXCR4; ERCC1; CD44; MDM2; PPARD; DDIT3; MPHOSPH8; FGFR3	2024-02-07	
Cladribine	Y	Y	N		N	1993	Y	<a href="https://go.drugbank.com/drugs/DB00242">DB00242</a>	L04AA40; L01BB04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1619">CHEMBL1619</a>	Chronic Lymphocytic Leukaemia (CLL); Cutaneous T-Cell Lymphoma (CTCL); Hairy Cell Leukemia (HCL); Non-Hodgkin&#39;s Lymphoma (NHL)	RRM2B; CDKN1A; DCK; NFE2L2; TGFB1; BCL2L2; RRM2; YES1; NT5C1A; TP53; ADA; DIABLO; RRM1; XIAP; IL2RA	2024-02-07	
Clofarabine	Y	Y	N		N	2004	Y	<a href="https://go.drugbank.com/drugs/DB00631">DB00631</a>	L01BB06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1750">CHEMBL1750</a>	Acute Lymphoblastic Leukaemia Recurrent; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myelogenous Leukemia (AML); Refractory Langerhans cell histiocytosis	POLA1; RRM1; POLE2; RRM2; POLE3; POLA2; AR; POLD2; POLD4; FLT3; POLE; POLD3; PRIM1; APBB1; POLD1; RRM2B; PRIM2	2024-02-07	
Cobimetinib	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB05239">DB05239</a>	L01EE02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2146883">CHEMBL2146883</a>	Metastatic Melanoma; Unresectable Melanoma	KRAS; MAP2K2; NRAS; BRAF; NF1; MAP2K3; ARAF; MAP2K1; RAF1; CDKN2A; PIK3CA; MAP2K5; MAP2K4; MAP2K6; MAP2K7; CBL	2024-02-07	
Copanlisib	N	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB12483">DB12483</a>	L01EM02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3218576">CHEMBL3218576</a>	Relapsed Follicular Lymphoma	PIK3CG; PIK3CA; PIK3CD; PIK3R3; PIK3R6; NRAS; AURKB; PIK3R4; PIK3C2G; PIK3CB; PIK3C3; PIK3R1; PIK3R2; PIK3R5; KIT; PIK3C2B; PIK3C2A; PTEN	2024-02-07	
Crizotinib	Y	Y	N		N	2011	N	<a href="https://go.drugbank.com/drugs/DB08865">DB08865</a>	L01ED01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL601719">CHEMBL601719</a>	Metastatic Non-Small Cell Lung Cancer	ABL1; IGF1R; TP53; BRAF; MET; ALK; NPM1; EML4; ROS1; NTRK2; EGFR; KIT; PIK3CA; ABCB1; ERBB2; HRAS; NTRK1; PTPN12; NTRK3; KRAS; JAK2; AREG	2024-02-07	
Cyclophosphamide	N	Y	Y		Y	1959	Y	<a href="https://go.drugbank.com/drugs/DB00531">DB00531</a>	L01AA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL88">CHEMBL88</a>	Acute Lymphoblastic Leukaemias (ALL); Acute Myelocytic Leukemia; Adenocarcinoma of the Ovaries; Breast Cancer; Burkitt&#39;s Lymphoma; Chronic Lymphocytic Leukaemia (CLL); Chronic Myeloid Leukemia (CML); Disseminated Neuroblastoma; Ewing&#39;s Sarcoma; Lung Cancers; Lymphoma, Hodgkins; Multiple Myeloma (MM); Non-Hodgkin&#39;s Lymphoma (NHL); Ovarian germ cell tumour; Pheochromocytomas; Retinoblastoma; Rhabdomyosarcomas; Waldenstrom&#39;s Macroglobulinemia (WM); Advanced Alibert-Bazin syndrome; Histiocytic lymphoma; Metastatic gestational trophoblastic tumor; Mixed-cell type lymphoma; Refractory Small cell lung cancer; Relapsed Wilm&#39;s tumor	EHMT2	2024-02-07	
Cytarabine	Y	Y	N		Y	1969	Y	<a href="https://go.drugbank.com/drugs/DB00987">DB00987</a>	L01BC01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL803">CHEMBL803</a>	Acute Lymphocytic Leukemia (ALL); Acute Myeloid Leukemia (AML); Acute Promyelocytic Leukemia (APL); Leptomeningeal Metastases; Meningeal leukemia; Non-Hodgkin&#39;s Lymphoma (NHL); Blast phase Chronic myelocytic leukemia	POLB; CYP2C9; GSTP1; FLT3; DOK5; NT5C2; RRM1; IDH2; CDA; NOS3; CSF2; SLCO1B1; CCND1; CYP2E1; VDR; POLD2; FCGR3A; BMP7; RRM2B; POLD1; POLA1; PRIM2; SLC22A12; NTRK1; SLC29A1; LINC00251; P2RY12; ABCC4; IDH1; DCK; ALK; CYP1A2; ITGAV; NCOA3; GATA3; IKZF1; KIT; GSTM1; CYP3A4; POLE2; CYP2C19; POLD4; TP53; IL1B; RRM2; CYP2D6; POLE3; BIRC5; POLE; POLD3; NT5C3A; NRAS; SULT2B1; XIAP; HSPA4; MED12L; ADH1A; ABCC3; RUNX1; FCGR3B; PRIM1; TP73; WT1; MAGEA1; EHMT2; POLA2; KMT2A; NRG1	2024-02-07	
Dabrafenib	Y	Y	N		N	2013	N	<a href="https://go.drugbank.com/drugs/DB08912">DB08912</a>	L01EC02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2028663">CHEMBL2028663</a>	Metastatic Melanoma; Unresectable Melanoma; Metastatic Non-small cell lung cancer with a BRAF V600E mutation; Pediatric  low-grade glioma (LGG) with a BRAF V600E mutation; Locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation	RAC1; MAP2K6; NRAS; CDKN2A; MAP2K1; ALK; PTEN; MAP2K2; PIK3CA; MAP2K5; HRAS; MAP2K7; MAP2K3; MAP2K4; ATXN1L; AKT1; HLA-DRB1; NF1; G6PD; TP53; MITF; EZH2; EML4; KRAS; BRAF	2024-02-07	
Dacarbazine	N	Y	Y		Y	1975	Y	<a href="https://go.drugbank.com/drugs/DB00851">DB00851</a>	L01AX04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL476">CHEMBL476</a>	Advanced Soft Tissue Sarcoma; Lymphoma, Hodgkins; Metastatic Melanoma; Pheochromocytomas; Advanced Medullary thyroid cancer; Advanced Pancreatic neuroendocrine tumor	FN1; PLAU; POLA2; CYP2D6; CYP1A2; ADK; BAX; EPM2AIP1; CYP2C19; CYP3A4; CXCL8; CYP2C9; GSTM1; MGMT	2024-02-07	
Dacomitinib	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB11963">DB11963</a>	L01EB07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110732">CHEMBL2110732</a>	Metastatic Non-Small Cell Lung Cancer	EGFR; ERBB4; ERBB3; ERBB2	2024-02-07	
Dactinomycin	N	Y	N		Y	1964	Y	<a href="https://go.drugbank.com/drugs/DB00970">DB00970</a>	L01DA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1554">CHEMBL1554</a>	Ewing&#39;s Sarcoma; Ovarian Cancer; Rhabdomyosarcomas; Sarcoma, Osteogenic; Wilms&#39; tumor; Metastatic nonseminomatous Testicular cancer	MTR; TFPI; BDNF; HTT; APEX1; BGLAP; RECQL; VDR; MTHFR; CD5; AR; THRB; TOP2A; BIRC5; CYP1A2; CYP3A4; ESR1; NR3C1; CEL; RXRA; COIL; TNFRSF1B; CYP2D6; CSF1; ALOX15; NRG1; PPARD; GRB2; AFP; PIK3CB; RORC; EHMT2; DDIT3; NTF3; TNFRSF8	2024-02-07	
Daratumumab	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB09331">DB09331</a>	L01FC01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743007">CHEMBL1743007</a>	Multiple Myeloma (MM); Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Relapsed Or Refractory Multiple Myeloma	CD38	2024-02-07	
Daratumumab, Hyaluronidase	N	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB09331">DB09331</a>	L01FC01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743007">CHEMBL1743007</a>	Multiple Myeloma (MM); Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Relapsed Or Refractory Multiple Myeloma	CD38	2024-02-07	
Darolutamide	Y	Y	N		N	2019	N	<a href="https://go.drugbank.com/drugs/DB12941">DB12941</a>	L02BB06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297185">CHEMBL4297185</a>	Non-mestatatic castrate-resistant prostate cancer	AR	2024-02-07	
Dasatinib	Y	Y	N		Y	2006	Y	<a href="https://go.drugbank.com/drugs/DB01254">DB01254</a>	L01EA02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1421">CHEMBL1421</a>	Acute Lymphoblastic Leukaemias (ALL); Chronic Myeloid Leukemia (CML)	ABL1; HRAS; MAP2K2; ABL2; EPHA2; KIT; LCK; PDGFRA; SRC; ARID1A; FYN; CBL; JAK2; KRAS; PDGFRB; MAP4K5; ABI1; YES1; ERBB4; IDH2; BTK; BCR; CSF3R; FGR; APC; TET2; LIMK1; LYN; DYRK3; FGFR1; MAPK14; BRAF; AR; ACVR1; TEC; FRK; SYK; GMNN; SRMS; IDH1; PKN2; ABCB1; HCK; MAP3K20; AXL; CDC42BPA; ABCG2; BLK; PPARD; AURKB; SMAD3; BRCA2; CSF1R; SIK2; SLK; NF1; MINK1; MAP3K10; ERBB2; FES; KDR; PTK6; CRKL; PLK4; MAP2K1; IRAK4; STAT5B; FGFR3; TNK2; DDR2; TAOK1	2024-02-07	
Daunorubicin	N	Y	Y		Y	1979	Y	<a href="https://go.drugbank.com/drugs/DB00694">DB00694</a>	L01DB02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL178">CHEMBL178</a>	Acute Lymphocytic Leukemia (ALL); Acute Myeloid Leukemia (AML); Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute erythroid leukemia; Acute monocytic leukaemia; Newly diagnosed Therapy-Related Acute Myeloid Leukemia	IDH1; SETD4; THRB; FLT3; SZRD1; SLC28A3; RECQL; MAN1B1; LINC00251; TOP2A; NPM1; HDAC2; BMP7; DCK; WT1; HDAC6; HDAC3; AKR1C4; ABCG2; RUNX1; DNMT3A; BLM; KDM4E; APP; TYMS; UGT1A6; HDAC10; ABCC1; HDAC9; HDAC7; ATP7B; PNPLA3; HDAC8; ANXA5; GSTP1; IKZF1; GATA3; CYP1A1; CBR1; FAS; CBR3; DOK5; MAPT; NOS3; TOP1; USP1; RARG; CDK2; CBFB; POLK; IDH2; MTHFR; NRP2; APEX1; SLCO1B1; KMT2A; AR; HDAC4; HDAC5; HTT; EHMT2; HDAC11; FMO3; AKR7A2; TOP2B; HDAC1; ABCB1; RPSA; AKR1C3	2024-02-07	
Daunorubicin, Cytarabine Liposome	Y	Y	N		N	2017	Y	<a href="https://go.drugbank.com/drugs/DB00694">DB00694</a>	L01XY01;  L01DB02		Acute Lymphocytic Leukemia (ALL); Acute Myeloid Leukemia (AML); Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute erythroid leukemia; Acute monocytic leukaemia; Newly diagnosed Therapy-Related Acute Myeloid Leukemia		2021-10-28	
Decitabine	Y	Y	N		N	2006	Y	<a href="https://go.drugbank.com/drugs/DB01262">DB01262</a>	L01BC08	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201129">CHEMBL1201129</a>	Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes (MDS)	DNMT1; TP53; IDH1; CCND2; CR2; CDKN2D; LIF; KRAS; DNMT3A; GSTP1; GMNN; THBS1; CTAG1B; IDH2; FLT3; IL2RA; TGM2; NR5A1; CYP27B1; APC; MUC2; MAGEA1	2024-02-07	
Decitabine , Cedazuridine	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/Not found in DrugBank">Not found in DrugBank</a>	L01BC58		Acute Myeloid Leukaemia		2023-08-01	
Degarelix	Y	Y	N		N	2008	N	<a href="https://go.drugbank.com/drugs/DB06699">DB06699</a>	L02BX02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL415606">CHEMBL415606</a>	Advanced Prostate Cancer	GNRHR; GNRHR2	2024-02-07	
Denileukin Diftitox	N	Y	N		N	1999	N	<a href="https://go.drugbank.com/drugs/DB00004">DB00004</a>	L01XX29	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201550">CHEMBL1201550</a>	Cutaneous T-Cell Lymphoma (CTCL)	IL2RA; IL12RB1; IL12RB2; IL2RB; IL2RG; EEF2	2024-02-07	
Denosumab	Y	Y	N		N	2010	N	<a href="https://go.drugbank.com/drugs/DB06643">DB06643</a>	M05BX04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1237023">CHEMBL1237023</a>	Giant cell tumor of the bone; Refractory Hypercalcemia of malignancy	TNFSF11; BRAF; TNFRSF11A	2024-02-07	
Dexamethasone	Y	Y	N		Y	1958	Y	<a href="https://go.drugbank.com/drugs/DB01234">DB01234</a>	S03BA01; S02BA06; S01CB01; S01BA01; R01AD03; H02AB02; D10AA03; D07XB05; D07AB19; C05AA09; A01AC02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL384467">CHEMBL384467</a>	Leukemia, Acute; Malignant Lymphomas; Multiple Myeloma (MM); Mycosis Fungoides (MF)	AR; HTR7; PYGL; NR3C1; RPS19; SFTPA1; NPPC; DOK5; CYP2C9; FOLR1; RARA; AGTR1; SI; CHKA; BIRC5; SMAD3; KDR; SOAT1; ANXA1; HYAL2; GATA3; THRSP; IRS2; LINC00251; NR1I2; CTLA4; HSPA8; CHAT; CDK4; F9; SDS; CDK2; TEAD1; VEGFA; TGFBR3; ALK; GLS; GSTP1; TDO2; CARTPT; S100A10; TG; NFE2L2; VCAM1; SAG; APOB; UBR1; NRG1; DPEP1; CCL17; GGT1; TJP1; UGT1A1; CD86; TYMS; MT1F; VDR; KRT19; CYP3A4; CYP1A2; SERPINE1; PTGDR; PTH1R; CTNNB1; FABP1; SLC2A4; CHRM3; CRISPLD2; RET; CDK6; RELA; CDH17; TSC22D3; IGFBP1; NR5A1; CYP2C19; NTRK1; JUNB; CYP2D6; JAK3; BMP7; ACTC1; LIF; PZP	2024-02-07	
Dexrazoxane	Y	Y	N		N	1995	Y	<a href="https://go.drugbank.com/drugs/DB00380">DB00380</a>	V03AF02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1738">CHEMBL1738</a>		TOP2B; TOP2A; CP; DPYS; MAPK8	2024-02-07	
Diethylstilbestrol	N	N	Y		N	1973	N	<a href="https://go.drugbank.com/drugs/DB00255">DB00255</a>	G03CC05; G03CB02; L02AA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL411">CHEMBL411</a>		ESR1; NPPC; HRAS; ESRRB; WNT7A; RORC; BDNF; TP53; AR; CYP2C19; ERBB2; NFE2L2; AMH; MYC; SLC5A7; CP; NR1I2; NR1H4; DNMT1; LPO; CYP2C9; BCL2; PTGES3; CYP3A4; CYP1A2; E2F1; GMNN; CYP2D6; ESRRG	2024-02-07	
Dinutuximab	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB09077">DB09077</a>	L01XC16	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137342">CHEMBL3137342</a>	High Risk Neuroblastoma	MYCN	2024-02-07	
Docetaxel	Y	Y	N		Y	1996	Y	<a href="https://go.drugbank.com/drugs/DB01248">DB01248</a>	L01CD02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL92">CHEMBL92</a>	Esophageal Cancers; Ewing&#39;s Sarcoma; Locally Advanced Breast Cancer (LABC); Metastatic Bladder Cancer; Metastatic Breast Cancer; Metastatic Hormone Refractory Prostate Cancer; Node Positive Breast Cancer; Ovarian Cancer Metastatic; Small Cell Lung Cancer (SCLC); Soft Tissue Sarcoma (STS); Advanced untreated gastric adenocarcinoma; Locally advanced Squamous cell carcinoma of head and neck; Locally advanced untreated non small cell lung cancer; Metastatic Squamous cell carcinoma of head and neck; Metastatic untreated non small cell lung cancer; Refractory, locally advanced Non small cell lung cancer; Refractory, metastatic Non small cell lung cancer	TUBB3; TP53; RXRA; TUBB2B; BCL2; STK11; ESR1; VAC14; TUBB8; ERBB3; TUBB1; RAF1; FGFR1; EPHX1; ADAMTSL4-AS1; PGR; CHST3; SOX10; SLCO1B1; PPARD; XRCC3; BRD4; AKR1C3; SULT1C4; ACSS2; ABCC6; SPG7; FOLH1; HNF4A; XRCC1; PGP; TUBB6; ESR2; TUBB; CASP7; ERBB2; CD44; MUC16; CYP2A6; TUBA1C; NR1I3; CYP1A1; TUBB4B; ABCC1; PIK3CA; TUBB4A; GSTM1; SNORD68; TUB; KRAS; SLC10A2; TUBA3C; PPCDC; NR1I2; MDM4; TLE3; DDIT3; TUBB2A; RPL13; OPRM1; PRDX4; CYP3A5; BAX; ORM2; GSTP1; KLK3; RNF8; GAS6; MTHFR; PTEN; CYP4B1; HRAS; MAP3K1; XRCC4; BIRC5; FGFR3; IGF2; FBXW7; TUBA3E; TUBA1B; TUBA4A; NAT2; ABCG2; ATP7A; TUBA1A	2024-02-07	
Dostarlimab	Y	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB15627">DB15627</a>	L01FF07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298124">CHEMBL4298124</a>	Adults with mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing regimen	MSH6; PDCD1; MLH1	2024-02-07	
Doxorubicin	N	Y	Y		Y	1974	Y	<a href="https://go.drugbank.com/drugs/DB00997">DB00997</a>	L01DB01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL53463">CHEMBL53463</a>	Acute Lymphoblastic Leukaemias (ALL); Acute Myeloblastic Leukemia; Advanced Endometrial Cancer; Advanced Soft Tissue Sarcoma; Bladder transitional cell carcinoma; Carcinoma, Bronchogenic; Gastric Carcinoma; Kaposi&#39;s Sarcoma AIDS Related; Lymphoma, Hodgkins; Malignant Lymphomas; Metastatic Breast Cancer; Multiple Myeloma (MM); Mycosis Fungoides (MF); Neuroblastomas; Ovarian Cancer Metastatic; Ovarian Carcinoma; Sarcoma, Bone; Sezary Syndrome; Soft Tissue Sarcoma (STS); Thyroid Carcinoma; Waldenstrom&#39;s Macroglobulinemia (WM); Wilms&#39; tumor; Advanced Thymoma; Advanced uterine sarcoma	TOP2A	2024-02-07	
Doxorubicin Liposome	Y	Y	N		N	1998	Y	<a href="https://go.drugbank.com/drugs/Not found in DrugBank">Not found in DrugBank</a>	L01DB01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL53463">CHEMBL53463</a>	Acute Lymphoblastic Leukaemias (ALL); Acute Myeloblastic Leukemia; Advanced Endometrial Cancer; Advanced Soft Tissue Sarcoma; Bladder transitional cell carcinoma; Carcinoma, Bronchogenic; Gastric Carcinoma; Kaposi&#39;s Sarcoma AIDS Related; Lymphoma, Hodgkins; Malignant Lymphomas; Metastatic Breast Cancer; Multiple Myeloma (MM); Mycosis Fungoides (MF); Neuroblastomas; Ovarian Cancer Metastatic; Ovarian Carcinoma; Sarcoma, Bone; Sezary Syndrome; Soft Tissue Sarcoma (STS); Thyroid Carcinoma; Waldenstrom&#39;s Macroglobulinemia (WM); Wilms&#39; tumor; Advanced Thymoma; Advanced uterine sarcoma	TOP2A	2024-02-07	
Durvalumab	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB11714">DB11714</a>	L01FF03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301587">CHEMBL3301587</a>	Unresectable Stage III Non-small Cell Lung Cancer; Urothelial carcinoma ureter metastatic; Locally advanced Urothelial Carcinoma; Unresectable, locally advanced PD-L1 positive Lung Cancer Non-Small Cell Cancer (NSCLC)	CD274; PBRM1; MLH1; ALK; ATM; IDH1; MSH2; MSH6	2024-02-07	
Duvelisib	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB11952">DB11952</a>	L01EM04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3039502">CHEMBL3039502</a>	Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL); Relapsed or Refractory Follicular Lymphoma; Refractory, relapsed small lymphocytic lymphoma	TP53; PIK3CD; PIK3CG	2024-02-07	
Edotreotide	Y	N	N		N	2019	N	<a href="https://go.drugbank.com/drugs/DB15494">DB15494</a>	V09IX09	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL408350">CHEMBL408350</a>	Neuroendocrine Tumors		2022-06-22	
Eflornithine	N	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB06243">DB06243</a>	L01XX79	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL830">CHEMBL830</a>	High Risk Neuroblastoma	TGM2; NR5A1; SMOX; XIAP; EHMT2; JUN; MTAP; PRL; KCNA1; ATF2; PLA2G2A; ODC1; ARG2; APC	2024-02-07	
Elacestrant	Y	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB06374">DB06374</a>	L02BA04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297509">CHEMBL4297509</a>	Advanced Breast Cancer, Metastatic Breast Cancer	ESR1	2024-02-07	
Elotuzumab	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB06317">DB06317</a>	L01FX08	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743010">CHEMBL1743010</a>	Refractory Multiple Myeloma	SLAMF7	2024-02-07	
Elranatamab	Y	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB15395">DB15395</a>	L01FX32	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297809">CHEMBL4297809</a>	Relapsed or Refractory Multiple Myeloma	TNFRSF17; CD3E; CD3D; CD3G	2024-02-07	
Emapalumab	N	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB14724">DB14724</a>	L04AA39	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989977">CHEMBL3989977</a>		UNC13D; STX11; IFNG; RAB27A; SH2D1A; STXBP2; XIAP; PRF1	2024-02-07	
Enasidenib	N	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB13874">DB13874</a>	L01XX59	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989908">CHEMBL3989908</a>	Refractory Acute Myelogenous Leukemia (AML); Relapsed Acute Myelogenous Leukemia (AML)	FLT3; IDH1; IDH2	2024-02-07	
Encorafenib	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB11718">DB11718</a>	L01EC03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301612">CHEMBL3301612</a>	Metastatic Melanoma; Unresectable Melanoma	BRAF; RAF1; PTEN; KRAS; TP53; ARAF; MAP2K1; HRAS; NRAS	2024-02-07	
Enfortumab Vedotin	Y	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB13007">DB13007</a>	L01FX13	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301589">CHEMBL3301589</a>	Locally Advanced Urothelial Cancer, Metastatic Urothelial Cancer	NECTIN4	2024-02-07	
Entrectinib	Y	Y	N		N	2019	N	<a href="https://go.drugbank.com/drugs/DB11986">DB11986</a>	L01EX14	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1983268">CHEMBL1983268</a>	Metastatic Solid Tumors; Non-Small Cell Lung Carcinoma (NSCLC); Tumors, Solid	BTK; PLK4; FER; AURKB; NTRK1; STK3; SLK; CLK4; ROS1; ALK; PRKCG; NTRK3; LYN; NTRK2; MET; TNK2; PKN2; LCK; JAK3; CSF1R; BLK; AURKA; TBK1; FLT4; PRKAA1; MST1R; RPS6KA3; KIT; ABL1; GRK5; SYK; CLK2; CDK7; HIPK2; FRK; TAOK1; EML4; KDR; IGF1R; MAP4K5; FLT1; FGFR1; LTK; PRKCQ; FGFR3; SRC; MAP4K2; FYN; FLT3; MAP4K4; LRRK2; AXL; RET; CAMK1D; PTK2; DAPK3; JAK2	2024-02-07	
Enzalutamide	Y	Y	N		N	2012	N	<a href="https://go.drugbank.com/drugs/DB08899">DB08899</a>	L02BB04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1082407">CHEMBL1082407</a>	Metastatic Castration Resistant Prostate Cancer	AR; PTEN; CYP17A1; PIK3CA; BRAF; CDK12; APC; TP53	2024-02-07	
Epcoritamab	Y	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB16672">DB16672</a>	L01FX27	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650393">CHEMBL4650393</a>	Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL)	CD3G; MS4A1; CD3D; CD3E	2024-02-07	
Epirubicin	N	Y	Y		N	1999	Y	<a href="https://go.drugbank.com/drugs/DB00445">DB00445</a>	L01DB03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL417">CHEMBL417</a>	Breast Cancer; Breast Cancer Stage II; Breast Cancer Stage III; Colorectal Cancers; Hormone Refractory Prostate Cancer; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Papillary transitional cell carcinoma of bladder; Recurrent Superficial Bladder Cancer; Small Cell Lung Cancer (SCLC); Soft Tissue Sarcoma (STS); Stomach Tumor; Carcinoma in situ of urinary bladder	PPP2R5D; RBX1; CYP2C8; FOXO1; PIK3R2; BIRC5; TP53AIP1; BCL2; SPIDR; CYP1B1; ABCC2; INSR; MDM4; CHD1; TUBB2A; CBR3; IRS1; GNL3; NOS1; ABCB1; PERP; EPHA6; TOP2A; SERPINE1; SLCO1B1; CCNK; ERBB2; HMMR; TP53; MISP; FOXP3	2024-02-07	
Erdafitinib	N	Y	N		N	2019	N	<a href="https://go.drugbank.com/drugs/DB12147">DB12147</a>	L01EN01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545376">CHEMBL3545376</a>	Locally Advanced, Susceptible FGFR3 or FGFR2 genetic alterations, Condition has progressed during or following at least one line of prior platinum- containing chemotherapy including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy urothelial carcinoma; Metastatic Susceptible FGFR3 or FGFR2 genetic alterations, Condition has progressed during or following at least one line of prior platinum- containing chemotherapy including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy Metastatic Urothelial Carcinoma	FGFR2; FGFR3; CYP2C9; FGFR4; FGFR1	2024-02-07	
Eribulin	Y	Y	N		N	2010	Y	<a href="https://go.drugbank.com/drugs/DB08871">DB08871</a>	L01XX41	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1683590">CHEMBL1683590</a>	Metastatic Liposarcoma; Refractory, metastatic Breast cancer; Unresectable Liposarcoma	TUBB4A; TUBA3C; ERBB2; TUBB3; ESR1; TUBB2A; CYP3A4; TUBB1; ESR2; CDK2; TUB; TUBB8; TUBA1A; TUBB6; TUBA3E; TUBB2B; TUBA4A; TERT; TUBA1B; TUBA1C; TUBB; PGR; TUBB4B	2024-02-07	
Erlotinib	Y	Y	N		Y	2004	Y	<a href="https://go.drugbank.com/drugs/DB00530">DB00530</a>	L01EB02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL553">CHEMBL553</a>	Locally Advanced Non-Small Cell Lung Cancer; Locally Advanced Pancreatic Cancer; Metastatic Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma (NSCLC); Pancreatic Cancer Metastatic	ERRFI1; FGFR3; NRG1; PKN2; FLT1; MAP3K1; FLT4; JAK2; SLK; HIPK4; MET; BIRC5; ROS1; LYN; MKNK2; ERBB2; ABL1; ABCB1; KDR; CYP1A2; LTK; PTEN; ERBB3; ERBB4; CYP2D6; APC; SYK; ALK; NF1; KRAS; FRK; IGF1R; CBL; PRKD2; FGFR4; AURKB; RET; AR; CLK4; PIK3CA; TP53; BRAF; EGFR; NF2; MAPK1; UGT1A1; MINK1; DDR2; BLK; YES1	2024-02-07	
Estramustine	N	Y	Y		N	1981	N	<a href="https://go.drugbank.com/drugs/DB01196">DB01196</a>	L01XX11	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1575">CHEMBL1575</a>	Metastatic Hormone Refractory Prostate Cancer	BAX; KLK3; BLM; KAT2A; BCL2; VDR; TDP1; AR; POLK; USP1; HEXB	2024-02-07	
Etoposide	N	Y	Y		Y	1983	Y	<a href="https://go.drugbank.com/drugs/DB00773">DB00773</a>	L01CB01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL44657">CHEMBL44657</a>	Acute Lymphoblastic Leukaemias (ALL); Acute Myeloid Leukemia (AML); Advanced Hodgkin&#39;s Lymphoma; Ewing&#39;s Sarcoma; Merkel cell cancer; Multiple Myeloma (MM); Neuroblastomas; Neuroendocrine Tumours; Non-Hodgkin&#39;s Lymphoma (NHL); Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Prostate Cancer; Retinoblastoma; Sarcoma, Osteogenic; Small Cell Lung Cancer (SCLC); Wilms&#39; tumor; Locally advanced Thymoma; Metastatic Thymic Cancer; Refractory Sarcoma; Refractory Testicular cancer	SF3B1; SLIT1; PLA2G1B; TOP2A; XIAP; E2F1; ABCC3; CYP2D6; TNFSF13B; KLK3; GSTM1; FGFR1; SLCO1B1; PGP; NCOA3; GSTP1; GMNN; BTF3P11; ABCC1; TP53; TGFB1; EIF4E; MAPK3; HSPB2; BCL2; NTRK3; CHEK1; SLC2A4; CYP1A2; UGT1A10; TOP2B; ACTR2; YAP1; CYP3A4; IGF2; DYNC2H1; MYCN; PAPOLA; AFP; NCOA1; TBP; ALK; CYP2C19; BAX; NQO1; GSTT1; MUC16; DDIT3; ITGAL; GLP1R; CYP2C9; ATM; PLA2G6; MAPK1; NR4A1; GDF15; BLMH	2024-02-07	
Everolimus	Y	Y	N		N	2009	Y	<a href="https://go.drugbank.com/drugs/DB01590">DB01590</a>	L04AA18; L01EG02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1908360">CHEMBL1908360</a>	Subependymal giant cell astrocytoma, tuberous sclerosis complex; Advanced Carcinoid tumor; Locally advanced gastrointestinal origin Progressive Neuroendocrine Tumors; Locally advanced lung origin Progressive Neuroendocrine Tumors; Metastatic gastrointestinal origin Progressive Neuroendocrine Tumors; Metastatic lung origin Progressive Neuroendocrine Tumors; Pancreatic origin Progressive Neuroendocrine Tumors; Refractory Advanced Renal Cell Carcinoma; Refractory Waldenstrom&#39;s Macroglobulinaemia; Refractory, advanced Breast cancer; Unresectable gastrointestinal origin Progressive Neuroendocrine Tumors; Unresectable lung origin Progressive Neuroendocrine Tumors	MTOR; ESR1; TSC1; PIK3CA; RPTOR; AR; ERBB2; CTNNB1; ARID1A; FGFR4; HRAS; FLT3; ATM; PBRM1; AKT1; AKT2; KDM5C; STK11; BRAF; NRAS; NF1; ESR2; NF2; KRAS; RET; PIK3R1; FLCN; CDKN2A; PTEN; VHL; AKT3; FKBP1A; BAP1; TSC2	2024-02-07	
Exemestane	N	Y	Y		N	1999	Y	<a href="https://go.drugbank.com/drugs/DB00990">DB00990</a>	L02BG06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200374">CHEMBL1200374</a>	Early Breast Cancer; Refractory, advanced Breast cancer	CYP1B1; KMT2C; IGF1R; ERBB2; ESR1; AKR1C3; BGLAP; PGR; CYP19A1; TUBB1; UGT2B17; NFE2L2; MAP4K4; AR; ESR2; TCL1A	2024-02-07	
Fedratinib	Y	Y	N		N	2019	N	<a href="https://go.drugbank.com/drugs/DB12500">DB12500</a>	L01EJ02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1287853">CHEMBL1287853</a>		JAK2; FLT3	2024-02-07	
Fludarabine	N	Y	Y		Y	1991	Y	<a href="https://go.drugbank.com/drugs/DB01073">DB01073</a>	L01BB05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1568">CHEMBL1568</a>	B-cell chronic lymphocytic leukemia/prolymphocytic leukemia/small lymphocytic lymphoma refractory; Refractory Non-Hodgkin&#39;s lymphoma	POLD1; ADA; CYP2B6; XIAP; DCK; PRIM2; POLA2; POLD3; RRM1; POLE; POLD4; PRIM1; SLCO1B1; POLE2; POLD2; ADH1A; BAX; MPO; CXCL12; SLC29A1; RRM2; NFE2L2; RRM2B; IKZF1; SULT2B1; POLE3; SMAD3; SLC22A12; POLA1; PIK3CG; ATM; CD40; CYP2E1	2024-02-07	
Fluorouracil	N	Y	Y		Y	1962	Y	<a href="https://go.drugbank.com/drugs/DB00544">DB00544</a>	L01BC02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL185">CHEMBL185</a>	Breast Cancer; Malignant Neoplasm of Colon; Malignant Neoplasm of Pancreas; Malignant Neoplasm of Stomach; Rectal Carcinoma; Superficial Basal Cell Carcinoma	HSPA5; EXO1; REV3L; ABCB1; MYB; ERCC1; MUTYH; KRAS; RALBP1; TYMS; CYP3A4; IL2RA; UPB1; KLC1; WNT5B; TP53; TOP2A; CBR3; XRCC3; ABCC5; DPYD; IL11; PARD3B; TSHB; IRS1; OSGEP; FGFR2; TPT1; PERP; GNAS; EGFR; DLG5; RBX1; CCNK; BRAF; INSR; FGFR4; HBB; TMEM167A; SMAD4; FPGS; ABCG1; PSMB3P1; AURKA; CCND1; CDKN1A; CYP2C8; NOS1; ALDH3A1; PIK3R2; ABCC4; CXCL8; TYMP; CYP19A1; PTPRC; COLEC10; NLGN1; ITGAL; NT5C1A; SLC22A16; SLC19A1; PIK3CA; ATM; SCN1A; ATRX; CYP2A6; GALNT14; CYP1B1; APEX1; RAD51C; ABCC2; CBR1; MEGF11; HMMR; NRAS; CYP2C19; PPP2R5D; IGFBP3; CYP2E1; PTEN; BDNF; KLC3; PALB2; CDC25C; GNL3; ABCC11; FAS; MTHFR; MUC2; OR10AE3P; SHMT1; IL6R; DTYMK; TWIST1; FOXO1; RGS5; ALCAM; SELE; MECP2; CHN2; LGR5; DKK1; BAX; BIRC5; TP53AIP1; E2F1	2024-02-07	
Fluoxymesterone	N	Y	N		N	1956	Y	<a href="https://go.drugbank.com/drugs/DB01185">DB01185</a>	G03BA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1445">CHEMBL1445</a>	Inoperable, metastatic Breast cancer	PRL; AR; NR3C1	2024-02-07	
Flutamide	N	Y	Y		N	1989	Y	<a href="https://go.drugbank.com/drugs/DB00499">DB00499</a>	L02BB01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL806">CHEMBL806</a>	C Prostatic Carcinoma; Stage B2 Prostatic Carcinoma; Stage D2 Prostatic carcinoma	PEBP1; AR; NFE2L2; EHMT2; CDKN1A; AQP9; RORC; CYP2C19; CYP1A2; CYP3A4; VIP; IL2RA; G6PD; KLK3; MPO; BIRC5; NR1I2; CYP2C9; TH	2024-02-07	
Fotemustine	Y	N	N		N			<a href="https://go.drugbank.com/drugs/DB04106">DB04106</a>	L01AD05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL549386">CHEMBL549386</a>	Metastatic Melanoma	MGMT; TXNRD1	2024-02-07	
Fruquintinib	N	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB11679">DB11679</a>	L01EK04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4303214">CHEMBL4303214</a>	Metastatic Colorectal Cancer	FLT1; KDR; FLT4	2024-02-07	
Fulvestrant	Y	Y	N		N	2002	Y	<a href="https://go.drugbank.com/drugs/DB00947">DB00947</a>	L02BA03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1358">CHEMBL1358</a>	Advanced or Metastatic Breast Cancer; Refractory, advanced Breast cancer; Refractory, metastatic Breast cancer	ESR1; FGFR2; PGR; NOS1; BDNF; ESR2; PTEN; CDK6; PIK3CA; ESRRA; ERBB2; CCNE1; ALK; XIAP; RB1; CYP1A2; EML4; EPHX2; FGF2; TP53; PIK3CG; TFPI	2024-02-07	
Futibatinib	Y	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB15149">DB15149</a>	L01EN04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3701238">CHEMBL3701238</a>	Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Unresectable Intrahepatic Cholangiocarcinoma	FGFR2; FGFR1; BRAF; NRAS; FGFR3; FGFR4	2024-02-07	
Gefitinib	Y	Y	N		Y	2003	Y	<a href="https://go.drugbank.com/drugs/DB00317">DB00317</a>	L01EB01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL939">CHEMBL939</a>	Metastatic Non-Small Cell Lung Cancer	EGFR; MAPK14; KRAS; PIM3; CYP2D6; RELA; ERBB3; IRAK4; ALK; ABCB1; ERBB2; LYN; TNK2; PTEN; CHEK2; BRSK1; MAPK10; CRKL; CYP3A5; CAMK2D; HIPK4; MET; MAPK8; CEACAM5; ERBB4; MAPT; YES1; IRAK1; PIK3CA; IGF1R; PRKD2; SIRT2; PBK; PLAU; PHKG2; FLT4; PIM1; BLK; BRAF; ROS1; MAPK9; AXL; EMP1; HCK; MINK1; SMO; FRK; GMNN; CAMK2G; IGF2; SIK2; LIMK1; LCK; MKNK2; MAP4K5; MAP3K1; SLK; CYP2C9; MAP4K4; CSNK1D; PRKD3	2024-02-07	
Gemcitabine	N	Y	Y		Y	1996	Y	<a href="https://go.drugbank.com/drugs/DB00441">DB00441</a>	L01BC05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL888">CHEMBL888</a>	Advanced Ovarian Cancer; Bladder Transitional Cell Carcinoma Stage IV; Cervical Cancers; Cutaneous T-Cell Lymphoma (CTCL); Head and Neck Carcinoma; Hodgkins Disease (HD); Locally Advanced Pancreatic Adenocarcinoma; Mesothelioma; Metastatic Breast Cancer; Non-Small Cell Lung Cancer Stage IIIB; Non-small Cell Lung Cancer (NSCLC), Stage IV; Non-small Cell Lung Cancer Stage IIIA; Small Cell Lung Cancer (SCLC); Stage 4 Pancreatic adenocarcinoma	SLC29A1; IGF2; PPCDC; POLD4; TNC; ACSS2; DDX53; OR4D6; RRM2B; TGM2; POLD1; ETS2; BTRC; SLCO1B1; HLA-C; IDH1; CBL; NT5C1A; POLR1G; CDA; HRAS; PIK3CA; CYP2C8; TNF; WEE1; RRM1; POLE2; NRG1; DOCK8; C6orf15; HCP5; PRRC2A; PPP1R18; MTHFD1; NRAS; SMAD4; SH2D5; TP53; BRCA1; MSH5; ESR2; UBASH3B; ALG10; PALB2; RRM2; ERCC1; ALOX5AP; CHEK1; FHL2; SERPINA5; BAZ2B; MS4A2; ERBB2; GPX5; POLE; RAF1; BRCA2; FANCC; XRCC1; MUCL3; PSORS1C1; PRB2; PPP1R13L; POLE3; FGFR3; DCP1B; POLD3; TENT4A; PRIM1; ATAT1; CDC5L; PRIM2; KLC3; SLC29A2; CAMK4; NT5C; POLD2; SERPINC1; CDSN; BRAF; XYLT2; WWOX; FKBP5; KRAS; CDKN2A; ATRX; PTEN; POLA2; CIP2A; POLA1; AR	2024-02-07	
Gemtuzumab Ozogamicin	Y	Y	N		N	2000	N	<a href="https://go.drugbank.com/drugs/DB00056">DB00056</a>	L01FX02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201506">CHEMBL1201506</a>	Acute Myeloid Leukemia (AML); Refractory Acute Myelogenous Leukemia (AML); Relapsed Acute Myelogenous Leukemia (AML)	SLCO1B1; SULT2B1; ADH1A; ABCB1; SLC22A12; CYP2E1; CHEK1; CD33; PML	2024-02-07	
Gilteritinib	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB12141">DB12141</a>	L01EX13	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301622">CHEMBL3301622</a>	Relapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations	AXL; FLT3; BRAF; CBL; NRAS; ALK; EML4; KIT; JAK3; IDH2; JAK2	2024-02-07	
Glasdegib	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB11978">DB11978</a>	L01XJ03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2043437">CHEMBL2043437</a>	Acute Myeloid Leukemia (AML)	SMO; MTOR; FLT3	2024-02-07	
Glofitamab	Y	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB16371">DB16371</a>	L01FX28	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/ CHEMBL4298092"> CHEMBL4298092</a>	Diffuse Large B-Cell Lymphoma (DLBCL), Large B Cell Lymphoma, Primary Mediastinal (Thymic) Large B Cell Lymphoma (PMBCL), Refractory Diffuse Large B Cell Lymphoma (DLBCL), Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B-Cell Lymphoma, Not Otherwise Specified	CD3D; CD3E; MS4A1; CD3G	2024-02-07	
Goserelin	N	Y	Y		N	1989	N	<a href="https://go.drugbank.com/drugs/DB00014">DB00014</a>	L02AE03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201247">CHEMBL1201247</a>	Advanced Breast Cancer; Early Breast Cancer; Advanced carcinoma of the prostate; Stage M1 hormone dependent carcinoma of the prostate; Stage T2b carcinoma of the prostate; Stage T2c carcinoma of the prostate; Stage T3 carcinoma of the prostate; Stage T4 carcinoma of the prostate	ESR2; LHCGR; GSR; ESR1; GNRHR; MYOD1; PGR; GNRH1	2024-02-07	
Histamine dihydrochloride	Y	Y	N		N	1939	N	<a href="https://go.drugbank.com/drugs/DB05381">DB05381</a>	L03AX14	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL90">CHEMBL90</a>	Acute Myeloid Leukaemia	SLC29A4; HRH4; HRH2; HRH1; EHMT2; USP1; LMNA	2024-02-07	
Histrelin	N	Y	N		N	1991	N	<a href="https://go.drugbank.com/drugs/DB06788">DB06788</a>	L02AE05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201255">CHEMBL1201255</a>	Advanced Prostate Cancer	GNRHR; GNRHR2	2024-02-07	
Hydroxyurea	N	Y	N		N	1967	Y	<a href="https://go.drugbank.com/drugs/DB01005">DB01005</a>	L01XX05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL467">CHEMBL467</a>	Essential Thrombocythemia (ET); Head and Neck Carcinoma; Melanomas; Ovarian Cancer Metastatic; Polycythemia Vera (PV); Chronic, refractory Myeloid Leukemia; Inoperable Ovarian cancer	MAP3K5; BLM; RRM2; RRM2B; SIN3A; EIF4E; KLF4; CP; HRAS; ABL1; PTH; ASS1; DNMT1; DNTT; CYP3A4; DUSP1; RRM1	2024-02-07	
Ibritumomab Tiuxetan	Y	Y	N		N	2002	N	<a href="https://go.drugbank.com/drugs/DB00078">DB00078</a>	V10XX02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201606">CHEMBL1201606</a>	Follicular Non-Hodgkin&#39;s Lymphoma; Follicular Non-Hodgkin&#39;s Lymphoma Refractory	MS4A1	2024-02-07	
Ibrutinib	Y	Y	N		N	2013	N	<a href="https://go.drugbank.com/drugs/DB09053">DB09053</a>	L01EL01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1873475">CHEMBL1873475</a>	Chronic Lymphocytic Leukaemia (CLL); Mantle Cell Lymphoma (MCL); Waldenstrom&#39;s Macroglobulinemia (WM)	BTK; YES1; MYD88; CYP2D6; PLCG2; MYC; LYN; FLT3; BMX; TP53; SMAD3; EGFR; ERBB2; ATM; PIM1; BLK; CSF3R	2024-02-07	
Idarubicin	N	Y	Y		N	1990	Y	<a href="https://go.drugbank.com/drugs/DB01177">DB01177</a>	L01DB06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1117">CHEMBL1117</a>	Acute Myeloid Leukemia (AML)	POLK; TOP2A; USP1; SLCO1B1; DRD1; NT5C3A; POLH; DNMT3A; ATAD5; FEN1; FLT3; AR; RECQL; RAPGEF4; CBX1; ADH1A; EHMT2; CYBA; SLC22A12; SULT2B1; BLM; ABCB1; KCNH2; ATXN2; POLI; PPARD; RAC2; CSF2; MTOR; IDH1; MPHOSPH8; POLB; WRN; DCK; NCF4; HTT; MAPT; RAPGEF3; APEX1; THRB; PLK1; ETV6; CYP2E1; ERG	2024-02-07	
Idecabtagene Vicleucel	Y	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB16665">DB16665</a>	L01XL07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298199">CHEMBL4298199</a>	Refractory Multiple Myeloma, Relapsed Multiple Myeloma	TNFRSF17	2024-02-07	
Idelalisib	Y	Y	N		N	2014	N	<a href="https://go.drugbank.com/drugs/DB09054">DB09054</a>	L01EM01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2216870">CHEMBL2216870</a>	Relapsed Chronic Lymphocytic Leukemia; Relapsed Small Lymphocytic Lymphoma; Relapsed follicular B-cell non-Hodgkin lymphoma	PIK3CD; BRAF; PIK3CA; TP53; PTEN	2024-02-07	
Ifosfamide	N	Y	Y		Y	1988	Y	<a href="https://go.drugbank.com/drugs/DB01181">DB01181</a>	L01AA06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1024">CHEMBL1024</a>	Cancer, Bladder; Cervical Cancers; Ewing&#39;s Sarcoma; Head and Neck Carcinoma; Lymphoma, Hodgkins; Malignant Neoplasm of Pancreas; Non-Hodgkin&#39;s Lymphoma (NHL); Ovarian Cancer; Sarcoma, Osteogenic; Small Cell Lung Cancer (SCLC); Soft Tissue Sarcoma (STS); Testicular Germ Cell Cancer; Advanced thymic carcinoma	TERC; GSTP1; DNMT1; HSPA4; TP53; MGMT; CYP2B6; NR1I2; ALK; CYP2A6; IL6	2024-02-07	
Imatinib	Y	Y	N		Y	2001	Y	<a href="https://go.drugbank.com/drugs/DB00619">DB00619</a>	L01EA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL941">CHEMBL941</a>	Chordomas; Chronic Eosinophilic Leukemia (CEL); Chronic Myeloid Leukemia (CML); Desmoid Tumors; FIP1L1-PDGFRa fusion kinase status unknown Chronic eosinophilic leukemia; Metastatic Gastrointestinal Stromal Tumor; Metastatic Melanoma; Myelodysplastic Syndromes (MDS); Refractory Acute Lymphoblastic Leukemia; Metastatic Dermatofibrosarcoma protuberans; Newly diagnosed Acute Lymphoblastic Leukaemia; Newly diagnosed, chronic phase Chronic myeloid leukemia; Recurrent Dermatofibrosarcoma protuberans; Refractory, accelerated phase Chronic myeloid leukemia; Refractory, blast crisis Chronic myeloid leukemia; Refractory, chronic phase Chronic myeloid leukemia; Systemic mastocytosis with associated hematological neoplasm; Unresectable Gastrointestinal stromal tumor	NTRK1; PDGFRA; RET; BRAF; ABL2; KIT; ABL1; ALK; SMAD3; SYK; CD40LG; quinone reductase 2; FIP1L1; PDGFRB; ABCB4; CYP2B6; PRKCH; IKZF1; LYN; TAOK1; PDGFB; IDH1; BCR; ABCB1; CSF1R; MAPK10; EYA2; CLK4; ABCC4; LCK; ABCG2; IRAK1; RAD52; CYP2F1; SLC19A1; ULK3; BCL2L11; NF1; PTEN; BIRC5; HCK; CYP3A5; GSTT1; NF2; RUNX1; SLCO1A2; CSF3R; SFN; HGF; KRAS; RUNDC3B; FGF2; CHST1; PIK3CG; UGT2A1; MYC; PVT1; CYP3A4; JAK2; EGFR; CTNNB1; ABCA3; XIAP; FRK; RCSD1; DDR1; SLC2A4; FLT3; ABI1; YES1	2024-02-07	
Imiquimod	Y	Y	N		N	1997	Y	<a href="https://go.drugbank.com/drugs/DB00724">DB00724</a>	D06BB10	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1282">CHEMBL1282</a>	Superficial Basal Cell Carcinoma	GMNN; IFNA1; TLR7	2024-02-07	
Infigratinib	N	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB11886">DB11886</a>	L01EN03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1852688">CHEMBL1852688</a>	Unresectable, locally advanced Cholangiocarcinomas, Unresectable, metastatic Cholangiocarcinomas	FGFR3; KIT; FGFR4; NRAS; FGFR1; FGFR2; PIK3R3; PIK3R2; PIK3R5; PIK3R4; PIK3C3; MTOR; PIK3CA; PTEN; PIK3C2B; PIK3CB; PIK3CG; PIK3CD; PIK3C2G; PIK3C2A; PIK3R1; PIK3R6	2024-02-07	
Inotuzumab Ozogamicin	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB05889">DB05889</a>	L01FB01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108611">CHEMBL2108611</a>	Refractory B-cell precursor acute lymphoblastic leukemia; Relapsed B cell precursor Acute lymphoblastic leukemia	CD22; BCR; ABL1	2024-02-07	
Interferon Alfa-2b	Y	Y	N		N	1986	N	<a href="https://go.drugbank.com/drugs/DB00105">DB00105</a>	L03AB05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201558">CHEMBL1201558</a>	Hairy Cell Leukemia (HCL); Kaposi&#39;s sarcoma; Melanoma, Malignant	IFNAR2; TP53; IFNA2; TGFB1; IFNAR1; FTO; ITPA; EIF2AK2; IFNG; IFNL4; CSF2; IL6; BAX; IL18	2024-02-07	
Iobenguane I-131	N	Y	N		N	1994	N	<a href="https://go.drugbank.com/drugs/DB06704">DB06704</a>	V09IX01; V09IX02; V10XA02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1615779">CHEMBL1615779</a>	Metastatic Pheochromocytoma; Metastatic Neuroblastoma; Primary Neuroblastomas; Primary Pheochromocytomas; Unresectable, locally advanced iobenguane-scan positive Paraganglioma; Unresectable, locally advanced iobenguane-scan positive Pheochromocytomas; Unresectable, metastatic iobenguane-scan positive Paraganglioma; Unresectable, metastatic iobenguane-scan positive Pheochromocytomas	TH; SLC6A2	2024-02-07	
Ipilimumab	Y	Y	N		N	2011	N	<a href="https://go.drugbank.com/drugs/DB06186">DB06186</a>	L01FX04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1789844">CHEMBL1789844</a>	Advanced Renal Cell Carcinoma; Cutaneous Melanoma; Hepatocellular Carcinoma; Metastatic Melanoma; Unresectable Melanoma; Metastatic MSI-H/dMMR colorectal cancer	CTLA4; CD274; BRAF; MDM2; EGFR; HLA-A; ALK; NRAS; PBRM1; TP53; MSH6; MLH1	2024-02-07	
Irinotecan	N	Y	Y		Y	1996	Y	<a href="https://go.drugbank.com/drugs/DB00762">DB00762</a>	L01CE02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL481">CHEMBL481</a>	Esophageal Cancers; Ewing&#39;s Sarcoma; Glioblastomas; Malignant Neoplasm of Pancreas; Malignant Neoplasm of Stomach; Metastatic Colorectal Carcinoma; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Rhabdomyosarcomas; Small Cell Lung Cancer (SCLC); Recurrent, IV-B Cervical cancer; Recurrent, metastatic Colorectal carcinoma; Refractory, metastatic Pancreatic adenocarcinoma	SEMA3C; TGFB1; PALB2; HSD17B10; TYMS; BCHE; TOP1; RGS5; ABCC5; ATM; E2F1; CES1; ISG15; UGT1A1; AREG; GSTM1; ABCC1; DCBLD1; KRAS; PIN1; MTHFR; RUNX3; AR; RAD50; MAPK10; PIK3CA; KCNQ5; CES2; UGT1A8; TOP1MT; KLC1; PLCB1; UBE2I; BRAF; DKK1; XRCC3; ABCG1; SHMT1; ABCC4; SLC19A1; GSTP1; PDZRN3; ATRX; BIRC5; RALBP1; C8orf34; ALK; TP53; MAP2K1; UGT1A10; MGMT; TGFBR2; TYMSOS; UGT1A; TDP1; FGFR3; CDKN1A; SLCO1B3; NRAS	2024-02-07	
Irinotecan Liposome	Y	Y	N		N	1996	Y	<a href="https://go.drugbank.com/drugs/DB00762">DB00762</a>	L01XX19	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL481">CHEMBL481</a>	Esophageal Cancers; Ewing&#39;s Sarcoma; Glioblastomas; Malignant Neoplasm of Pancreas; Malignant Neoplasm of Stomach; Metastatic Colorectal Carcinoma; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Rhabdomyosarcomas; Small Cell Lung Cancer (SCLC); Recurrent, IV-B Cervical cancer; Recurrent, metastatic Colorectal carcinoma; Refractory, metastatic Pancreatic adenocarcinoma	SEMA3C; TGFB1; PALB2; HSD17B10; TYMS; BCHE; TOP1; RGS5; ABCC5; ATM; E2F1; CES1; ISG15; UGT1A1; AREG; GSTM1; ABCC1; DCBLD1; KRAS; PIN1; MTHFR; RUNX3; AR; RAD50; MAPK10; PIK3CA; KCNQ5; CES2; UGT1A8; TOP1MT; KLC1; PLCB1; UBE2I; BRAF; DKK1; XRCC3; ABCG1; SHMT1; ABCC4; SLC19A1; GSTP1; PDZRN3; ATRX; BIRC5; RALBP1; C8orf34; ALK; TP53; MAP2K1; UGT1A10; MGMT; TGFBR2; TYMSOS; UGT1A; TDP1; FGFR3; CDKN1A; SLCO1B3; NRAS	2024-02-07	
Isatuximab	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB14811">DB14811</a>	L01FC02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545131">CHEMBL3545131</a>	Multiple Myeloma (MM)	CD38	2024-02-07	
Ivosidenib	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB14568">DB14568</a>	L01XX62	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989958">CHEMBL3989958</a>	Newly diagnosed, refractory or relapsed Acute Myeloid Leukemia; Relapsed or refractory Myelodysplastic Syndromes with IDH1 mutation; Locally Advanced or Metastatic Cholangiocarcinoma with IDH1 mutation	IDH2; IDH1	2024-02-07	
Ixabepilone	N	Y	N		N	2007	N	<a href="https://go.drugbank.com/drugs/DB04845">DB04845</a>	L01DC04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201752">CHEMBL1201752</a>	Locally Advanced Breast Cancer (LABC); Metastatic Breast Cancer	TUBB4B; TUBA1A; PGR; TUBB1; ESR1; TUBB3; ESR2; TUBA1B; TUBB; CYP3A4; TUBA3E; TUBB4A; TUBB6; ERBB2; TUBB2A; TUBA4A; TUBB2B; TUBB8; TUBA3C; TUB; TUBA1C	2024-02-07	
Ixazomib	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB09570">DB09570</a>	L01XG03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296">CHEMBL2141296</a>	Multiple Myeloma (MM)	PSMA7; PSMB10; PSMA2; PSMA4; PSMB11; PSMD2; PSMD1; PSMA1; PSMD14; PSMD12; PSMB8; PSMC1; TP53; PSMD13; SEM1; PSMB3; PSMB9; PSMB5; PSMD11; PSMC5; ADRM1; PSMC6; PSMA8; PSMA5; PSMC2; PSMA3; PSMB1; PSMD7; PSMD4; PSMB6; PSMD3; PSMD6; PSMB7; PSMA6; PSMC4; EML4; ALK; PSMB2; PSMD8; PSMC3; PSMB4	2024-02-07	
Lanreotide	N	Y	Y		N	2007	N	<a href="https://go.drugbank.com/drugs/DB06791">DB06791</a>	H01CB03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201185">CHEMBL1201185</a>	Unresectable, locally advanced enteropancreatic neuroendocrine tumors; Unresectable, locally advanced gastroenteropancreatic neuroendocrine tumors; Unresectable, metastatic enteropancreatic neuroendocrine tumors; Unresectable, metastatic gastroenteropancreatic neuroendocrine tumors	EDN1; SSTR1; SSTR2; SSTR5	2024-02-07	
Lapatinib	Y	Y	N		N	2007	Y	<a href="https://go.drugbank.com/drugs/DB01259">DB01259</a>	L01EH01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL554">CHEMBL554</a>	Metastatic Breast Cancer; Refractory, advanced Breast cancer; Refractory, metastatic Breast cancer	ERBB2; PGR; EGFR; HLA-DRB1; BRAF; AURKB; ESR1; HLA-DQA1; PTEN; PIK3CA; RET; MET; ERBB4; ERBB3; CYP3A4; ABCB11; BIRC5; ESR2; CDKN1B; YES1; NF2; CCND1; NRG1; CYP3A5; KRAS; EEF2K	2024-02-07	
Larotrectinib	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB14723">DB14723</a>	L01EX12	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3889654">CHEMBL3889654</a>	NTRK1 Fusion Positive; NTRK2 Fusion Positive; NTRK3 Fusion Positive	NTRK1; NTRK3; NTRK2	2024-02-07	
Lenalidomide	Y	Y	N		Y	2005	Y	<a href="https://go.drugbank.com/drugs/DB00480">DB00480</a>	L04AX04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL848">CHEMBL848</a>	Chronic Lymphocytic Leukemia (CLL) - Refractory; Follicular Lymphoma (FL); Mantle Cell Lymphoma (MCL); Marginal Zone Lymphoma (MZL); Multiple Myeloma (MM); Myelodysplastic Syndrome; Refractory Diffuse Large B Cell Lymphoma	TP53; CTNNB1; DDB1; FGF2; KDR; RBX1; CRBN; VEGFA; CUL4A; VEGFC; VEGFB; TNFSF11; TNF	2024-02-07	
Lenvatinib	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB09078">DB09078</a>	L01EX08	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1289601">CHEMBL1289601</a>	Advanced Renal Cell Carcinoma; Locally recurrent radioactive iodine-refractory Thyroid cancer; Metastatic radioactive iodine-refractory Thyroid cancer; Progressive radioactive iodine-refractory Thyroid cancer	FGFR2; KDR; NRAS; PDGFRA; YES1; FLT1; RET; PDGFRB; BRAF; KIT; FLT4; FGFR1	2024-02-07	
Letrozole	N	Y	Y		N	1997	Y	<a href="https://go.drugbank.com/drugs/DB01006">DB01006</a>	L02BG04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1444">CHEMBL1444</a>	Advanced Breast Cancer; Early Breast Cancer; Ovarian Epithelial Cancer; Advanced HR + HER2 - breast cancer; Metastatic HR + HER2 - breast cancer	ESR1; ESR2; CYP19A1; PTEN; RB1; SFTPA1; PGR; CTNNB1; CYP3A4; ERBB2; CYP2A6; KIT; TNFRSF11B; KMT2C; CDKN2A; PIK3CA; TNFSF11; MMP2; CYP1B1	2024-02-07	
Leuprolide	N	Y	N		N	1985	Y	<a href="https://go.drugbank.com/drugs/DB00007">DB00007</a>	L02AE51; L02AE02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201199">CHEMBL1201199</a>	Advanced Prostate Cancer	GNRHR	2024-02-07	
Lisocabtagene Maraleucel	Y	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB16582">DB16582</a>		<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297236">CHEMBL4297236</a>	Grade 3b Follicular Lymphoma; High-grade B-cell Lymphoma (HGBCL); Primary mediastinal large B-cell lymphomas; Refractory Diffuse Large B Cell Lymphoma; Refractory Large B-cell Lymphoma; Relapsed Large B-cell Lymphoma; Relapsed, Diffuse Large B-cell Lymphoma	CD19	2024-02-07	
Lomustine	N	Y	Y		N	1976	N	<a href="https://go.drugbank.com/drugs/DB01206">DB01206</a>	L01AD02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL514">CHEMBL514</a>	Primary Brain Tumors; Refractory Hodgkin Lymphoma; Tumors Metastatic to Brain	MGMT; IDH1; ADK; EGFR	2024-02-07	
Loncastuximab Tesirine	Y	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB16222">DB16222</a>	L01FX22	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297778">CHEMBL4297778</a>	Refractory Large B-cell Lymphoma, Relapsed Large B-cell Lymphoma	CD19	2024-02-07	
Lorlatinib	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB12130">DB12130</a>	L01ED05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3286830">CHEMBL3286830</a>	Progressive, metastatic Anaplastic lymphoma kinase-positive Metastatic Non-Small Cell Lung Cancer	NRAS; ALK; EML4; TP53; ROS1; HRAS; RB1; BRAF; PIK3CA; FGFR1	2024-02-07	
Lu 177-Dotatate	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB13985">DB13985</a>	V10XX04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989924">CHEMBL3989924</a>	Gastroenteropancreatic Neuroendocrine Tumors	SSTR1; SSTR5; SSTR3; SSTR4; SSTR2	2024-02-07	
Lurbinectedin	N	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB12674">DB12674</a>	L01XX69	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297516">CHEMBL4297516</a>	Metastatic Small Cell Lung Cancer		2020-09-17	
Lutetium Lu 177 Vipivotide Tetraxetan	Y	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB16778">DB16778</a>	V10XX05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594406">CHEMBL4594406</a>	Metastatic Castration Resistant Prostate Cancer (CRPC)	FOLH1	2024-02-07	
Margetuximab	N	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB14967">DB14967</a>	L01FD06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2364649">CHEMBL2364649</a>	HER2-positive Metastatic Breast Cancer	ERBB2; FCGR2B; FCGR2A; ERBB3; FCGR3A	2024-02-07	
Mechlorethamine	Y	Y	N		N	1949	N	<a href="https://go.drugbank.com/drugs/DB00888">DB00888</a>	L01AA05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL427">CHEMBL427</a>	Carcinoma, Bronchogenic; Chronic Lymphocytic Leukaemia (CLL); Hodgkins Disease (HD); Lymphoma, Diffuse; Mycosis Fungoides (MF); Polycythemia Vera (PV); Stage I Mycosis Fungoides; Malignant effusion	MMP2; TSHB; CXCR2; ERBB2; MT-CO1; CSF2; GSTP1; BAX; XRCC1; NOS1; GSR	2024-02-07	
Medroxyprogesterone	N	Y	Y		N	1959	Y	<a href="https://go.drugbank.com/drugs/DB00603">DB00603</a>	G03DA02; G03AC06; L02AB02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL717">CHEMBL717</a>	Metastatic Renal Cell Carcinoma; Metastatic Endometrial carcinoma	ESR1; PGR; CYP3A5; CYP1B1; VDR; MMP1; BAX	2024-02-07	
Megestrol Acetate	N	Y	Y		N	1971	Y	<a href="https://go.drugbank.com/drugs/DB00351">DB00351</a>	G03DB02; G03AC05; L02AB01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201139">CHEMBL1201139</a>	Advanced Breast Cancer; Advanced Endometrial Cancer	ESR1; IL15; NPSR1; IL2RA; AR; KLK3; PGR; ABCB1; NFE2L2	2024-02-07	
Melphalan	N	Y	Y		Y	1964	Y	<a href="https://go.drugbank.com/drugs/DB01042">DB01042</a>	L01AA03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL852">CHEMBL852</a>	Multiple Myeloma (MM); Ovarian Epithelial Cancer; Severe Hodgkin Lymphoma	NFE2L2; SLC7A5; ABCB1; EHMT2; POLR1G; ABL1; FANCC; MGMT; AR; TP53; RORC; OPLAH; CTLA4; GSTP1; PLAT; NR1H4; ABCC1; CYP3A4; CDKN1A; CDK12; IFNG	2024-02-07	
Melphalan Flufenamide	Y	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB16627">DB16627</a>	L01AA10	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4303060">CHEMBL4303060</a>	Relapsed Or Refractory Multiple Myeloma	NFE2L2; SLC7A5; ABCB1; EHMT2; POLR1G; ABL1; FANCC; MGMT; AR; TP53; RORC; OPLAH; CTLA4; GSTP1; PLAT; NR1H4; ABCC1; CYP3A4; CDKN1A; CDK12; IFNG	2024-02-07	
Mercaptopurine	Y	Y	N		Y	1953	Y	<a href="https://go.drugbank.com/drugs/DB01033">DB01033</a>	L01BB02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1425">CHEMBL1425</a>	Acute Lymphoblastic Leukaemias (ALL); Acute Promyelocytic Leukemia (APL); Lymphoma, Lymphoblastic	TP53; ALDH1A1; SLC29A2; TPMT; HPRT1; CYP2C9; FOLH1; TDP1; KDM4E; BAZ2B; NUDT15; VCAM1; HBB; IMPDH1; XDH; KDM4A; HLA-DQA1; IL2RA; CYP2C19; PRPS1; HLA-DRB1; CYP1A2; PPAT; IDH1; GATA3; NT5C2; MTHFR; FTO; CYP3A4; SLC28A3; NFE2L2; SLCO1B1; GSTP1; CYP2D6; GNMT	2024-02-07	
Methotrexate	Y	Y	N		Y	1953	Y	<a href="https://go.drugbank.com/drugs/DB00563">DB00563</a>	L04AX03; L01BA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL34259">CHEMBL34259</a>	Acute Lymphocytic Leukemia (ALL); Acute Promyelocytic Leukemia (APL); Breast Cancer; Cancer, Bladder; Central Nervous System Lymphoma; Choriocarcinoma; Head and Neck Carcinoma; Meningeal leukemia; Sarcoma, Osteogenic; Small Cell Lung Cancer (SCLC); Soft Tissue Sarcoma (STS); Squamous Cell Carcinoma of Lung; Advanced Alibert-Bazin syndrome; Advanced non-Hodgkin lymphoma; Nonleukemic meningeal cancer	SLC22A11; CCND1; ABCC4; PYGL; ENG; FOLR1; NFE2L2; BAX; HLA-E; DHFR; CDK9; KLRD1; SPECC1L; BIRC5; HSPB2; POLH; SLC16A7; NTRK3; C1orf167; NR1I2; ALK; GSTT1; NCOA3; FCGR3B; HGF; NOS3; EHMT2; TLR4; E2F1; GLS; GSTM1; CYP1A2; SLC46A1; S100A8; PPARG; TARDBP; NR3C1; ARID5B; CYP2C9; S100A12; SULT2A1; SLCO1A2; ADORA2A; ENOSF1; TPM3; SOD2; LINC00251; MSH3; VDR; TP53; ERCC2; COL18A1; FOXP3; CYP2C19; FPGS; GATA3; NQO1; CDH2; NOP2; CYP2D6; ATP5F1E; ALOX5; FGFR4; APEX1; MPHOSPH8; HLA-C; TNFAIP3; SLC19A1; IKZF1; ADORA2A-AS1; CYP3A4; PTPN22; ATIC; KIR2DS4; IL2; AFP; BMP7; NTRK1; TAT; GSK3B; SLCO1B1; SLC22A8; SLAMF1; POLB; NALCN; FLT3; TYMS; FOLH1; KCNA1; ICAM3; HSD17B10; ADA; POLI; IDH1; CDKN1B; IL1RN; DOK5; SLC22A9	2024-02-07	
Midostaurin	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB06595">DB06595</a>	L01EX10	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL608533">CHEMBL608533</a>	Acute Myeloid Leukemia (AML); Malignant mast cell neoplasm; Systemic mastocytosis with associated hematological neoplasm	NTRK3; FGFR1; PIK3CB; KIT; PRKD1; FLT3; PRKCD; PRKCQ; IL6; PRKCG; PRKCE; PIK3CA; PRKCA; STK32B; PRKCH; PDGFRA; PRKCB; NPM1; PRKCI; IL2; HSPA4; CBL; PRKCZ; IDH2; JAK3; PRKD3; JAK2; PDGFRB; YES1; KDR; FGFR3; TNF	2024-02-07	
Mifamurtide	Y	N	N		N	2009	N	<a href="https://go.drugbank.com/drugs/DB13615">DB13615</a>	L03AX15	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107354">CHEMBL2107354</a>	High-grade, nonmetastatic Osteosarcoma; Resectable, nonmetastatic Osteosarcoma	NOD2	2024-02-07	
Mirvetuximab Soravtansine	N	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB12489">DB12489</a>	L01FX26	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545132">CHEMBL3545132</a>	Platinum Resistant Primary Peritoneal Cancer, Platinum-resistant Epithelial Ovarian Cancer, Platinum drug resistant Fallopian tube cancer	TUBB2A; TUBB1; TUBB6; TUBA1B; TUBB8; TUBA1C; TUBA3C; TUBB3; TUBB; TUBA1A; TUBA4A; TUBB4B; FOLR1; TUBA3E; TUBB4A; TUBB2B	2024-02-07	
Mitomycin	N	Y	Y		N	1981	Y	<a href="https://go.drugbank.com/drugs/DB00305">DB00305</a>	L01DC03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL105">CHEMBL105</a>	Adenocarcinoma of the Pancreas; Adenocarcinoma of the Stomach; Breast Cancer; Cancer, Anal; Cancer, Bladder; Cervical Cancers; Head and Neck Carcinoma; Mesothelioma; Non-Small Cell Lung Carcinoma (NSCLC); Low-grade Upper Tract Urothelial Cancer (LG-UTUC)	BGLAP; DHFR; TP53; TYMS; CYP2C9; CYP2C19; BRCA1; VWF; IL1A; CGB5; CYP7B1; CYP2D6; FANCC; ABCB1; AR; LGALS2; TAT; XDH; CYP1A2; ABCB4; CYP3A4; MAPK10; KRT18; PALB2	2024-02-07	
Mitoxantrone	N	Y	Y		N	1987	Y	<a href="https://go.drugbank.com/drugs/DB01204">DB01204</a>	L01DB07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL58">CHEMBL58</a>	Acute Lymphocytic Leukemia (ALL); Acute Myeloid Leukemia (AML); Acute Promyelocytic Leukemia (APL); Lymphoma, Hodgkins; Metastatic Breast Cancer; Non-Hodgkin&#39;s Lymphoma (NHL); Relapsed Leukemia; Relapsed Lymphomas; Hormone refractory, advanced Prostate cancer; Relapsed Hepatocellular carcinoma	CYP3A4; ABCG2; MECP2; MBNL1; GALNT14; POLH; RPSA; POLK; RACGAP1; UGT1A5; MAPK1; SLCO1B1; RECQL; BRCA1; WRN; ARSA; SMAD3; TOP2A; RGS4; BCL2; NSD2; YES1; NFKB1; RAD52; KDM4A; CBX1; EHMT2; HTT; POLI; ABCB1; PIM1; BAX; MPHOSPH8; C10orf67; TP53; DNMT1; FLT3; THPO; BLM; ATAD5; ATXN2; FEN1	2024-02-07	
Mobocertinib	N	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB16390">DB16390</a>	L01EB10	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650319">CHEMBL4650319</a>	Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer	EGFR	2024-02-07	
Mogamulizumab	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB12498">DB12498</a>	L01FX09	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743041">CHEMBL1743041</a>	Refractory Mycosis Fungoides/Sezary Syndrome; Relapsed Mycosis Fungoides/Sezary Syndrome	CCR4	2024-02-07	
Mosunetuzumab	Y	N	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB15434">DB15434</a>	L01FX25	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297788">CHEMBL4297788</a>	Relapsed follicular lymphoma, Refractory follicular lymphoma	CD3D; MS4A1; CD3E; CD3G	2024-02-07	
Moxetumomab Pasudotox	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB12688">DB12688</a>	L01FB02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743043">CHEMBL1743043</a>	Relapsed/Refractory Hairy Cell Leukemia	EEF2; CD22	2024-02-07	
Nab-Paclitaxel	Y	Y	N		N	2005	Y	<a href="https://go.drugbank.com/drugs/Not found in DrugBank">Not found in DrugBank</a>	L01CD01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL428647">CHEMBL428647</a>	Advanced Cervical Cancer; Advanced Head and Neck Cancer; Advanced Ovarian Cancer; Advanced Soft Tissue Sarcoma; Esophageal Cancers; Fallopian Tube Cancer; Kaposi&#39;s sarcoma; Locally Advanced Non-Small Cell Lung Cancer; Malignant Neoplasm of Stomach; Malignant Peritoneal Neoplasm; Metastatic Bladder Cancer; Metastatic Breast Cancer; Metastatic Melanoma; Metastatic Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Pancreatic Adenocarcinoma Metastatic; Advanced Bladder cancer; Advanced Thymoma; Metastatic Penile cancer; Refractory Small cell lung cancer; Refractory Testicular germ cell cancer	SOD2; TUBA3C; TRIM5; FASN; NAT2; FZD3; FGD4; ERCC2; CDKN1A; FCGR2A; LIF; MAP3K1; TUBB4B; RRM1; SYK; EIF4E2; BIRC5; AURKA; TP53; OPRM1; BCL2; ABCB1; TUBA3D; NFE2; EPHA6; TUBA1A; TUBB3; TUBB4A; TUBB; ROS1; ERBB2; TUBA3E; FNTB; GSTP1; EDNRB; PIK3CA; E2F1; ETS2; TLE3; IL2RA; JAK2; CXCL8; ABCC1; GSTT1; TUBA4A; SLCO1B1; AR; FOS; ABCC10; RAD51C; EPHA5; TIGD1; SPIDR; CDK2; NR1I2; GMNN; GSTM1; BDNF; CYP3A; EIF4EBP1; ATM; ABCC3; SLC29A1; ABCC2; DSCAM; TUBB6; TOP2A; TUBB1; RAF1; TUBB2B; TUBA1C; NOP2; FGFR1; ABCG2; MYB; PIK3CG; TYMS; BRCA1; CASP7; NRG1; SLCO1B3; CHEK1; PGP; AFG2A; MMP2; DDIT3; STMN1; PTEN; EGFR; SOX10; MAD1L1; TUBB2A; ACSS2; PDCD4; CASP3; TUBA1B; TUBB8; RB1; MISP; ERCC1; CYP3A5; ARHGEF10; KRAS	2024-02-07	
Nab-Sirolimus	N	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB00877">DB00877</a>	L04AH01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL413">CHEMBL413</a>	Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)	ADAMTSL4-AS1; MTOR; RBL2; AR; FLCN; APC; POR; NFE2L2; NRAS; TSC1; RPS6KB1; IL10; PRKAA1; EGFR; BAX; DDIT3; IL17A; TP53; ALK; EIF4E; ABCG2; PTEN; HRAS; RB1; TCF7L2; WT1; TGM2; CDKN2A; IL7; JAK2; CRLF2; ITGAL; DCN; PIM1; FBXW7; MMP1; CTLA4; NR1I2; MAPK10; FGFR1; IGFBP1; PGR; RPTOR; PLAU; FKBP4; FGF2; ERBB2; RHEB; IL15; ABCB1; NOS1; FKBP1A; PIK3CA; OPRK1; DDC; NF1; EML4	2024-02-07	
Nadofaragene Firadenovec	N	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB17381">DB17381</a>	L01XL10	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3990041">CHEMBL3990041</a>	High risk BCG-unresponsive non-muscle invasive bladder cancer	IFNA2	2024-02-07	
Naxitamab	N	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB15965">DB15965</a>	L01FX21	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297984">CHEMBL4297984</a>	High risk, refractory Neuroblastomas of the bone or bone marrow; High risk, relapsed Neuroblastomas of the bone or bone marrow		2022-10-23	
Necitumumab	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB09559">DB09559</a>	L01FE03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743047">CHEMBL1743047</a>	Metastatic Non-Small Cell Lung Cancer	EGFR	2024-02-07	
Nelarabine	Y	Y	N		N	2005	Y	<a href="https://go.drugbank.com/drugs/DB01280">DB01280</a>	L01BB07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201112">CHEMBL1201112</a>	Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukemia) refractory; Refractory Acute Lymphoblastic Leukemia	POLA1; NT5C2	2024-02-07	
Neratinib	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB11828">DB11828</a>	L01EH02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL180022">CHEMBL180022</a>	Breast Cancer	ERBB2; ERBB4; CBL; BRAF; PGR; ESR1; YES1; EGFR; PIK3CA; KDR; ESR2; HERC2	2024-02-07	
Nilotinib	Y	Y	N		Y	2007	N	<a href="https://go.drugbank.com/drugs/DB04868">DB04868</a>	L01EA03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL255863">CHEMBL255863</a>	Chronic Phase Chronic Myeloid Leukemia; Refractory Gastrointestinal stromal tumor; Refractory, accelerated phase Chronic myeloid leukemia	ABI1; FLT3; BCR; KIT; PDGFRA; ABCG2; UGT1A1; CYP3A4; PDGFRB; NF1; DDR2; ABL1	2024-02-07	
Nilutamide	N	Y	N		N	1996	Y	<a href="https://go.drugbank.com/drugs/DB00665">DB00665</a>	L02BB02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1274">CHEMBL1274</a>	Metastatic Hormone Refractory Prostate Cancer	CYP2C19; CYP2D6; AR; CYP3A4; NFE2L2; CYP2C9; PRL; KLK3; CYP1A2	2024-02-07	
Nintedanib	Y	Y	N		N	2014	Y	<a href="https://go.drugbank.com/drugs/DB09079">DB09079</a>	L01EX09	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL502835">CHEMBL502835</a>	Locally advanced Non-Small Cell Lung Cancer (NSCLC) caused by Adenocarcinoma; Locally recurrent Non-Small Cell Lung Cancer (NSCLC) caused by Adenocarcinoma; Metastatic Non-Small Cell Lung Cancer (NSCLC) caused by Adenocarcinoma	FGFR3; KDR; CFLAR; PDGFRB; PDGFRA; FGFR2; FGFR1; FGFR4; FLT1; RET; KIT; FLT4; AKT1; PIK3CA	2024-02-07	
Niraparib	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB11793">DB11793</a>	L01XK02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1094636">CHEMBL1094636</a>	Fallopian Tube Cancer; Ovarian Epithelial Cancer; Primary Peritoneal Cancer	PARP1; ATM; MYCN; RAD51C; BRCA1; ATR; ARID1A; FANCA; CHEK2; IDH1; SLFN11; PALB2; PTEN; BRCA2; CDK12; PARP2; BRIP1	2024-02-07	
Nirogacestat Hydrobromide	N	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB12005">DB12005</a>	L01XX81	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298153">CHEMBL4298153</a>	Progressive Desmoid Tumors		2024-02-01	
Nivolumab	Y	Y	N		Y	2015	N	<a href="https://go.drugbank.com/drugs/DB09035">DB09035</a>	L01FF01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108738">CHEMBL2108738</a>	Advanced Renal Cell Cancer; Classical Hodgkin&#39;s Lymphoma; Hepatocellular Carcinoma; Low Risk Advanced Renal Cell Cancer; Melanomas; Metastatic Colorectal Cancer (MCRC); Metastatic Melanoma; Metastatic Non-Small Cell Lung Cancer; Metastatic Small Cell Lung Cancer; Metastatic Squamous Cell Carcinoma of the Head and Neck; Metastatic Urothelial Carcinoma (UC); Recurrent Head and Neck Squamous Cell Carcinoma; Unresectable Melanoma; Intermediate risk Advanced Renal Cell Cancer; Locally advanced Urothelial Carcinoma	PTEN; CD274; PDCD1; CDK12; BRAF; MDM2; ALK; MLH1; IDH1; PMS2; FGFR3; KRAS; TP53; EGFR; HLA-DRA; NRAS; PBRM1; ARID1A; MDM4; STK11; MSH6; ERBB2	2024-02-07	
Obinutuzumab	Y	Y	N		N	2013	N	<a href="https://go.drugbank.com/drugs/DB08935">DB08935</a>	L01FA03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743048">CHEMBL1743048</a>	Refractory Follicular Lymphoma; Previously untreated Chronic lymphocytic leukemia	MS4A1; TP53	2024-02-07	
Ofatumumab	Y	Y	N		N	2009	N	<a href="https://go.drugbank.com/drugs/DB06650">DB06650</a>	L04AA52; L01FA02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201836">CHEMBL1201836</a>	Chronic Lymphocytic Leukaemia (CLL); Chronic Lymphocytic Leukemia (CLL) - Refractory; Progressive Chronic Lymphocytic Leukaemia (CLL); Recurrent Chronic Lymphocytic Leukaemia (CLL)	MS4A1	2024-02-07	
Olaparib	Y	Y	N		N	2014	N	<a href="https://go.drugbank.com/drugs/DB09074">DB09074</a>	L01XK01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL521686">CHEMBL521686</a>	Fallopian Tube Cancer; Malignant Peritoneal Neoplasm; Metastatic Breast Cancer; Ovarian Epithelial Cancer; Primary Peritoneal Cancer; Advanced deleterious germline or somatic BRCA-mutated advanced epithelial ovarian cancer; Advanced deleterious germline or somatic BRCA-mutated fallopian tube cancer; Advanced deleterious germline or somatic BRCA-mutated peritoneal cancer; Refractory Advanced Ovarian Cancer	PPP2R2A; ATM; RAD54L; PARP1; PGR; PARP3; PARP2; BRCA1; ATRX; CHEK1; IDH2; ERBB2; ESR1; ARID1A; PALB2; MYC; KDM6A; BRCA2; ESR2; IDH1; FANCA; MYCN; SF3B1; BARD1; CHEK2; ATR; NRAS; HDAC2; RAD51B; PTEN; PIK3CA; RAD51D; VHL; FANCL; CDK12; BRIP1; BAP1; RAD51C; TP53	2024-02-07	
Olaratumab	Y	Y	N		N	2016	N	<a href="https://go.drugbank.com/drugs/DB06043">DB06043</a>	L01FX10	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743049">CHEMBL1743049</a>	Soft Tissue Sarcoma (STS)	PDGFRA	2024-02-07	
Olutasidenib	N	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB16267">DB16267</a>		<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297610">CHEMBL4297610</a>	Refractory Acute Myeloid Leukemia (AML), Relapsed Acute Myelogenous Leukemia (AML)	IDH1	2024-02-07	
Omacetaxine Mepesuccinate	N	Y	N		N	2009	N	<a href="https://go.drugbank.com/drugs/DB04865">DB04865</a>	L01XX40	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL46286">CHEMBL46286</a>	Refractory, accelerated phase Chronic myeloid leukemia; Refractory, chronic phase Chronic myeloid leukemia	BIRC5; ABL1; TERT; FLT3; BCR	2024-02-07	
Osimertinib	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB09330">DB09330</a>	L01EB04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3353410">CHEMBL3353410</a>	Metastatic Non-Small Cell Lung Cancer	MET; EGFR; PIK3CA; ERBB2; ROS1; ALK; TP53; CTNNB1; BRAF; PTEN; NRAS	2024-02-07	
Oxaliplatin	N	Y	Y		Y	2002	Y	<a href="https://go.drugbank.com/drugs/DB00526">DB00526</a>	L01XA03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL414804">CHEMBL414804</a>	Advanced Colorectal Cancer; Advanced Ovarian Cancer; Advanced Pancreatic Cancer; Chronic Lymphocytic Leukemia (CLL) - Refractory; Colon Cancer Stage III; Esophageal Cancers; Malignant Neoplasm of Stomach; Advanced biliary adenocarcinoma; Refractory Neuroendocrine Tumour; Refractory Non-Hodgkin&#39;s lymphoma; Refractory Testicular cancer	PIN1; FGFR2; ABL1; KRAS; BRCA1; KLC3; PTGS2; ATP7A; ABCC2; PTEN; DPYD; SELE; PALB2; GNA13; MT1A; PARD3B; MGAT4A; ATP7B; GSTP1; PIK3CA; TP53; ABCC5; ZEB1; DKK1; BAX; ATM; MTHFR; FOXC2; CXCL10; BRAF; BCL2; CSMD1	2024-02-07	
Paclitaxel	Y	Y	N		Y	1992	Y	<a href="https://go.drugbank.com/drugs/DB01229">DB01229</a>	L01CD01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL428647">CHEMBL428647</a>	Advanced Cervical Cancer; Advanced Head and Neck Cancer; Advanced Ovarian Cancer; Advanced Soft Tissue Sarcoma; Esophageal Cancers; Fallopian Tube Cancer; Kaposi&#39;s sarcoma; Locally Advanced Non-Small Cell Lung Cancer; Malignant Neoplasm of Stomach; Malignant Peritoneal Neoplasm; Metastatic Bladder Cancer; Metastatic Breast Cancer; Metastatic Melanoma; Metastatic Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Pancreatic Adenocarcinoma Metastatic; Advanced Bladder cancer; Advanced Thymoma; Metastatic Penile cancer; Refractory Small cell lung cancer; Refractory Testicular germ cell cancer	SOD2; TUBA3C; TRIM5; FASN; NAT2; FZD3; FGD4; ERCC2; CDKN1A; FCGR2A; LIF; MAP3K1; TUBB4B; RRM1; SYK; EIF4E2; BIRC5; AURKA; TP53; OPRM1; BCL2; ABCB1; TUBA3D; NFE2; EPHA6; TUBA1A; TUBB3; TUBB4A; TUBB; ROS1; ERBB2; TUBA3E; FNTB; GSTP1; EDNRB; PIK3CA; E2F1; ETS2; TLE3; IL2RA; JAK2; CXCL8; ABCC1; GSTT1; TUBA4A; SLCO1B1; AR; FOS; ABCC10; RAD51C; EPHA5; TIGD1; SPIDR; CDK2; NR1I2; GMNN; GSTM1; BDNF; CYP3A; EIF4EBP1; ATM; ABCC3; SLC29A1; ABCC2; DSCAM; TUBB6; TOP2A; TUBB1; RAF1; TUBB2B; TUBA1C; NOP2; FGFR1; ABCG2; MYB; PIK3CG; TYMS; BRCA1; CASP7; NRG1; SLCO1B3; CHEK1; PGP; AFG2A; MMP2; DDIT3; STMN1; PTEN; EGFR; SOX10; MAD1L1; TUBB2A; ACSS2; PDCD4; CASP3; TUBA1B; TUBB8; RB1; MISP; ERCC1; CYP3A5; ARHGEF10; KRAS	2024-02-07	
Padeliporfin	Y	N	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB15575">DB15575</a>	L01XD07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298112">CHEMBL4298112</a>	Low-Risk Prostate Cancer of the one lobe only		2020-09-17	
Palbociclib	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB09073">DB09073</a>	L01EF01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL189963">CHEMBL189963</a>	Advanced Breast Cancer; Metastatic Breast Cancer; Refractory, advanced Breast cancer; Refractory, metastatic Breast cancer	ERBB2; CCND2; MST1R; DAPK3; CCND3; SMARCA4; CCNE2; CDK4; FLT3; ESR1; ALK; NRAS; PRKAA1; NEK2; DYRK1A; PGR; CCND1; MAP4K5; CDK9; PIK3CA; MAPK9; CHEK2; ESR2; KRAS; LRRK2; TAOK1; CCNE1; CDKN2A; CDK5; DYRK1B; TP53; PAK4; MAP4K2; PTEN; PRKD3; CHEK1; RET; MET; ROCK2; CDKN2B; CLK4; PRKX; BRAF; MAPK8; CLK2; CDK6; MAP4K4; RB1; RPS6KA3	2024-02-07	
Panitumumab	Y	Y	N		N	2006	N	<a href="https://go.drugbank.com/drugs/DB01269">DB01269</a>	L01FE02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201827">CHEMBL1201827</a>	Metastatic Colorectal Cancer (MCRC)	PTEN; TGFA; BRAF; BTC; HBEGF; TP53; MAP2K1; NRAS; EGFR; NRG1; CDKN2A; HRAS; KRAS; EREG; NRG3; AREG; PIK3CA; MET; NRG2	2024-02-07	
Panobinostat	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB06603">DB06603</a>	L01XH03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL483254">CHEMBL483254</a>	Refractory Multiple Myeloma	HDAC2; SIRT3; HDAC1; HDAC4; MYCN; HDAC5; CSF1R; SIRT6; HDAC3; SIRT5; HDAC7; BAP1; HDAC9; ACTL6A; HDAC11; HDAC8; HDAC10; SIRT7; BRAF; SIRT4; SMARCB1; KMT2A; SIRT2; SIRT1; HDAC6	2024-02-07	
Pazopanib	Y	Y	N		N	2009	Y	<a href="https://go.drugbank.com/drugs/DB06589">DB06589</a>	L01EX03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL477772">CHEMBL477772</a>	Advanced Renal Cell Carcinoma; Advanced Soft Tissue Sarcoma; Advanced Thyroid cancer	KDR; NRAS; AURKB; PDGFRB; FLT1; KIT; LCK; PDGFRA; ALK; RET; HDAC2; AR; CYP2C8; CYP3A4; FGFR2; TP53; TNK2; UGT1A1; ABCG2; FLT4; MET; YES1; ABL1; CDK7; TAOK1; MTOR; FGFR1; MAP4K4; IGF1R; FGFR3; VHL; MAPK8; CXCL8; FYN; CSF1R; SCGB3A1; AURKA; PPARD; LTK; NEK2; NR1I2; PTK2; LIMK1; HLA-B; EWSR1; MAPK9; VEGFA; NF1	2024-02-07	
Pegaspargase	Y	Y	N		Y	1994	N	<a href="https://go.drugbank.com/drugs/DB00059">DB00059</a>	L01XX24	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108546">CHEMBL2108546</a>	Acute Lymphoblastic Leukaemias (ALL)	HLA-DRB1; DOK5; LINC00251; ARHGAP28; HLA-DQB1; BMP7; GATA3	2024-02-07	
Peginterferon Alfa-2b	Y	Y	N		N	2001	N	<a href="https://go.drugbank.com/drugs/DB00022">DB00022</a>	L03AB10	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201561">CHEMBL1201561</a>	Melanomas	HLA-DPA1; CYP2R1; IFNL3; IFNAR2; VDR; IFIT1; SLC6A4; IFNA2; DNAAF9; HLA-A; SLC28A2; MICB; HLA-C; IL21R; JAK2; OAS1; KIR2DS2; TUT7; CARD16; HLA-B; CASP1; IFNAR1; KLRK1; IL18; EGFR; IL6; CXCL10; CYP27B1; SLC29A1; SOCS3; CTLA4; OASL	2024-02-07	
Pembrolizumab	Y	Y	N		Y	2014	N	<a href="https://go.drugbank.com/drugs/DB09037">DB09037</a>	L01FF02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137343">CHEMBL3137343</a>	Advanced Renal Cell Carcinoma; Cervical Cancers; Colorectal Cancers; Metastatic Melanoma; Metastatic Solid Tumors; Unresectable Melanoma; Urothelial carcinoma ureter metastatic; Locally advanced Urothelial Carcinoma; Locally advanced gastroesphageal juntion adenocarcinoma; Metastatic gastroesphageal juntion adenocarcinoma; Metastatic nonsquamous non-small cell lung cancer; Recurrent, metastatic Head and Neck Squamous Cell Carcinoma; Refractory, metastatic Non small cell lung cancer; Refractory, relapsed Hodgkin Lymphoma; Refractory, relapsed Mediastinal Large B-cell Lymphoma; Unresectable Solid Tumors	MLH1; BRAF; IDH1; FBXW7; PTEN; CD274; PBRM1; HLA-DRA; JAK1; ARID1A; TP53; ERBB2; MDM4; MSH6; NRAS; PDCD1LG2; B2M; ROS1; CDK12; ALK; PDCD1; JAK2; KIT; POLE; EGFR; MDM2; KRAS; STK11	2024-02-07	
Pemetrexed	Y	Y	N		N	2004	Y	<a href="https://go.drugbank.com/drugs/DB00642">DB00642</a>	L01BA04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL225072">CHEMBL225072</a>	Mesothelioma; Ovarian Cancer; Pleural Mesotheliomas; Urothelial carcinoma ureter metastatic; Locally advanced nonsquamous non-small cell lung cancer; Metastatic nonsquamous non-small cell lung cancer; Recurrent, IV-B Cervical cancer; Unresectable Thymoma	RRM1; XRCC1; GGH; MTHFR; ROS1; TYMS; FOLR3; ERCC2; MTHFD1; ALK; KRAS; SLC46A1; GART; ABCC2; PTEN; SLC19A1; ATIC; DHFR; EGFR	2024-02-07	
Pemigatinib	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB15102">DB15102</a>	L01EN02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297522">CHEMBL4297522</a>	Unresectable, locally advanced Cholangiocarcinomas; Unresectable, metastatic Cholangiocarcinomas	FGFR1; FGFR3; FGFR2	2024-02-07	
Pentostatin	N	N	Y		N	1991	Y	<a href="https://go.drugbank.com/drugs/DB00552">DB00552</a>	L01XX08	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1580">CHEMBL1580</a>	B-Lymphocytic, prolymphocytic leukemia (Kiel Classification) refractory; Chronic Lymphocytic Leukaemia (CLL); Hairy Cell Leukemia (HCL); Mycosis Fungoides (MF); Sezary Syndrome	ADA; PRKAA1	2024-02-07	
Pertuzumab	Y	Y	N		N	2012	N	<a href="https://go.drugbank.com/drugs/DB06366">DB06366</a>	L01FD02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2007641">CHEMBL2007641</a>	Early Breast Cancer; Inflammatory Breast Cancer (IBC); Locally Advanced Breast Cancer (LABC); Metastatic Breast Cancer	ERBB2; NRG1; ESR2; ESR1; EGFR; PGR; ERBB3	2024-02-07	
Pertuzumab, Trastuzumab, Hyaluronidase	Y	Y	N		N	2020		<a href="https://go.drugbank.com/drugs/Not found in DrugBank">Not found in DrugBank</a>	L01XY02				2021-10-28	
Pipobroman	N	N	Y		N	1966		<a href="https://go.drugbank.com/drugs/DB00236">DB00236</a>	L01AX02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1585">CHEMBL1585</a>		ALDH1A1; KDM4E; NFE2L2	2024-02-07	
Pirarubicin	N	N	N	Japan	N			<a href="https://go.drugbank.com/drugs/DB11616">DB11616</a>	L01DB08	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2354444">CHEMBL2354444</a>		USP1; MYCN; POLK; KMT2A; GLS; TP53; ABCC1; FEN1; HTT	2024-02-07	
Pirtobrutinib	Y	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB17472">DB17472</a>	L01EL05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650485">CHEMBL4650485</a>	Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma	BTK	2024-02-07	
Pixantrone	Y	N	N		N	2012	N	<a href="https://go.drugbank.com/drugs/DB06193">DB06193</a>	L01DB11	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL167731">CHEMBL167731</a>	Non-Hodgkin&#39;s Lymphoma, Relapsed; Refractory Non-Hodgkin&#39;s lymphoma	TOP2A	2024-02-07	
Polatuzumab Vedotin	Y	Y	N		N	2019	N	<a href="https://go.drugbank.com/drugs/DB12240">DB12240</a>	L01FX14	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301582">CHEMBL3301582</a>	Diffuse Large B-Cell Lymphoma (DLBCL)	TUBB4B; TUBB2A; CD79B; TUBA1A; TUBA3E; TUBA1C; TUBB2B; TUBB4A; TUBA3C; TUBB8; TUBB; TUBB1; TUBA1B; TUBB6; TUBB3; TUBA4A	2024-02-07	
Polyestradiol Phosphate	N	N	Y		N	1957		<a href="https://go.drugbank.com/drugs/DB09369">DB09369</a>	L02AA02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201477">CHEMBL1201477</a>		ESR1; AFP; NOS1	2024-02-07	
Pomalidomide	Y	Y	N		N	2013	Y	<a href="https://go.drugbank.com/drugs/DB08910">DB08910</a>	L04AX06	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL43452">CHEMBL43452</a>	Refractory Multiple Myeloma	CUL4A; DDB1; RBX1; CRBN	2024-02-07	
Ponatinib	Y	Y	N		N	2012	N	<a href="https://go.drugbank.com/drugs/DB08901">DB08901</a>	L01EA05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1171837">CHEMBL1171837</a>	Accelerated phase chronic myologenic leukemia; Acute Lymphoblastic Leukaemias (ALL); Chronic Phase Chronic Myeloid Leukemia; Blast phase Chronic myelocytic leukemia	FLT3; PDGFRA; KIT; FGFR1; FGFR2; FGFR3; ABL1; FGFR4; PDGFRB; EML4; ABL2; BCR; BRAF; KRAS; ABI1; YES1; SRC; KDR; RET	2024-02-07	
Porfimer	Y	Y	N		N	1995	N	<a href="https://go.drugbank.com/drugs/DB00707">DB00707</a>	L01XD01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201481">CHEMBL1201481</a>	Esophageal Cancers; Completely obstructive Non-small cell lung cancer; Microinvasive endobrachial Non-small cell lung cancer; Partially obstructive Non-small cell lung cancer		2020-09-17	
Pralatrexate	Y	Y	N		N	2009	Y	<a href="https://go.drugbank.com/drugs/DB06813">DB06813</a>	L01BA05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201746">CHEMBL1201746</a>	Cutaneous T-Cell Lymphoma (CTCL); Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-cell Lymphoma Unspecified	DHFR; RFC1; PDF	2024-02-07	
Pralsetinib	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB15822">DB15822</a>	L01EX23	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297597">CHEMBL4297597</a>	Metastatic RET-fusion Non Small Cell Lung Cancer	RET; CCDC6; KIF5B; EML4	2024-02-07	
Prednisolone	Y	Y	N		Y	1955	Y	<a href="https://go.drugbank.com/drugs/DB00860">DB00860</a>	S03BA02; S02BA03; S01CB02; S01BA04; R01AD02; H02AB06; D07XA02; D07AA03; C05AA04; A07EA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL131">CHEMBL131</a>	Hypercalcemia of Malignancy; Leukemia, Acute; Malignant Lymphomas; Mycosis Fungoides (MF)	TG; DSE; NFE2L2; MTHFR; CYP3A5; NR3C1; HMGB1; CD34; CYP3A4; RPS19; ALPP; BGLAP; BAX; G6PD; PNPLA3; TAT; ANXA1; PLG; AR; TSPYL1; FCGR3B; FCGR3A; LCAT	2024-02-07	
Prednisone	N	Y	Y		N	1955	Y	<a href="https://go.drugbank.com/drugs/DB00635">DB00635</a>	H02AB07; A07EA03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL635">CHEMBL635</a>	Acute Lymphoblastic Leukaemias (ALL); Aggressive Lymphoma; Hypercalcemia of Malignancy; Leukemia, Acute; Leukemias; Malignant Lymphomas; Metastatic Castration Resistant Prostate Cancer; Mycosis Fungoides (MF)	ATM; BMP7; DOK5; NCF4; MYC; NR3C1; MC2R; APOE; HSD17B10; NFATC1; TPMT; AR; CYP3A4; CHEK2; GSTA1; CTLA4; PALB2; PTPRC; CYP1A2; GSTM1; CYBA; ANXA1; ITGB2; CYP2D6; MBP; GSTP1; ABCB1; GATA3; BRIP1; LINC00251; CYP2C9; EDNRA; FANCA; CYP2C19; VWF; NOS3; CALCA; CDK12; SLC19A1; TG; CXCL12; IFNG	2024-02-07	
Procarbazine	N	Y	Y		Y	1969	N	<a href="https://go.drugbank.com/drugs/DB01168">DB01168</a>	L01XB01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1321">CHEMBL1321</a>	Non-Hodgkin&#39;s Lymphoma (NHL); Oligodendrogliomas; Primary Central Nervous System Lymphoma (PCNSL); Stage III Hodgkin&#39;s Disease; Stage IV Hodgkin&#39;s Disease	BAX; EPM2AIP1; ALOX15; CSF2; CYP1A2	2024-02-07	
Quizartinib	Y	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB12874">DB12874</a>	L01EX11	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/ CHEMBL576982"> CHEMBL576982</a>	Newly Diagnosed Acute Myeloid Leukemia (AML)	PDGFRA; NRAS; JAK3; FGF2; PDGFRB; KIT; CBL; CSF1R; RET; IDH2; FLT3	2024-02-07	
Racotumomab	N	N	N	Cuba, Argentina	N			<a href="https://go.drugbank.com/drugs/DB13045">DB13045</a>		<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743059">CHEMBL1743059</a>			2020-09-17	
Radium 223 Dichloride	Y	Y	N		N	2013	N	<a href="https://go.drugbank.com/drugs/DB08913">DB08913</a>	V10XX03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107816">CHEMBL2107816</a>	Castration resistant, metastatic Prostate cancer		2020-09-17	
Raltitrexed	N	N	Y	Canada	N	1996	N	<a href="https://go.drugbank.com/drugs/DB00293">DB00293</a>	L01BA03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL225071">CHEMBL225071</a>	Advanced Colorectal Cancer; Pleural Mesotheliomas	ALB; TYMS; DHFR; CDKN1B; CDK2; SLC19A1	2024-02-07	
Ramucirumab	Y	Y	N		N	2014	N	<a href="https://go.drugbank.com/drugs/DB05578">DB05578</a>	L01FG02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743062">CHEMBL1743062</a>	Advanced Gastric Cancer; Advanced gastro-esophageal junction adenocarcinoma; Refractory, metastatic Colorectal cancer; Refractory, metastatic Non small cell lung cancer	KDR; PDGFRA; ALK; KRAS; EGFR	2024-02-07	
Ranimustine	N	N	N	Japan	N			<a href="https://go.drugbank.com/drugs/DB13832">DB13832</a>	L01AD07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105348">CHEMBL2105348</a>			2020-09-22	
Realgar-Indigo Naturalis Formulation	N	N	N	China	Y	2009		<a href="https://go.drugbank.com/drugs/Not found in DrugBank">Not found in DrugBank</a>	L01XX27		Acute promyelocytic leukaemia		2021-03-10	
Regorafenib	Y	Y	N		N	2012	N	<a href="https://go.drugbank.com/drugs/DB08896">DB08896</a>	L01EX05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1946170">CHEMBL1946170</a>	Hepatocellular Carcinoma; Metastatic Colorectal Cancer (MCRC); Metastatic Gastrointestinal Stromal Tumor; Locally advanced Gastrointestinal stromal tumor; Unresectable Gastrointestinal stromal tumor	MAPK11; RET; ARAF; FGFR2; FLT4; BRAF; EPHA2; FRK; DDR2; ZHX2; TEK; FGFR3; RAF1; KDR; PDGFRB; KRAS; FLT1; FGFR1; PTEN; MAP2K1; NRAS; VEGFA; FBXW7; ABL1; PIK3CA; EGFR; NTRK1; PDGFRA; YES1; KIT; VHL	2024-02-07	
Relatlimab ,  Nivolumab	Y	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB14851">DB14851</a>	L01XY03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3990044">CHEMBL3990044</a>; <a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108738">CHEMBL2108738</a>	Metastatic Melanoma, Unresectable Melanoma		2024-02-07	
Relugolix	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB11853">DB11853</a>	L02BX04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1800159">CHEMBL1800159</a>	Advanced Prostate Cancer	GNRHR; LHCGR	2024-02-07	
Repotrectinib	N	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB16826">DB16826</a>	L01EX28	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298138">CHEMBL4298138</a>	locally active or metastatic non-small cell lung cancer	NTRK1; ALK; EML4; ROS1; NTRK3	2024-02-07	
Retifanlimab	N	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB15766">DB15766</a>	L01FF10	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298037">CHEMBL4298037</a>	Metastatic Locally Advanced Merkel Cell Carcinoma, Recurrent, locally advanced Merkel Cell Carcinoma	PDCD1	2024-02-07	
Ribociclib	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB11730">DB11730</a>	L01EF02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545110">CHEMBL3545110</a>	Advanced Breast Cancer; Metastatic Breast Cancer	NRAS; BRAF; RB1; PGR; CDK4; CCND1; CDK6; CDKN2A; ALK; PIK3CA; PTEN; CCND2; ESR1; ESR2; SMARCA4; CCND3; ERBB2; JAK2	2024-02-07	
Ripretinib	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB14840">DB14840</a>	L01EX19	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4216467">CHEMBL4216467</a>	Advanced Gastrointestinal Stromal Tumor (GIST)	KIT; PDGFRA; PDGFRB	2024-02-07	
Rituximab	Y	Y	N		Y	1997	N	<a href="https://go.drugbank.com/drugs/DB00073">DB00073</a>	L01FA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201576">CHEMBL1201576</a>	Chronic Lymphocytic Leukaemia (CLL); Non-Hodgkin&#39;s Lymphoma (NHL)	MS4A1; GSTA1; IL2; FCGR3A; FCGR2A; ABCB1; NCF4; TGFB1; TP53; CYBA; IL6; XIAP; CXCL12; CXCL13; RPS19	2024-02-07	
Rituximab, Hyaluronidase	N	Y	N		N	1997	N	<a href="https://go.drugbank.com/drugs/DB00073">DB00073</a>	L01XC02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201576">CHEMBL1201576</a>	Chronic Lymphocytic Leukaemia (CLL); Non-Hodgkin&#39;s Lymphoma (NHL)	MS4A1; GSTA1; IL2; FCGR3A; FCGR2A; ABCB1; NCF4; TGFB1; TP53; CYBA; IL6; XIAP; CXCL12; CXCL13; RPS19	2024-02-07	
Romidepsin	Y	Y	N		N	2009	Y	<a href="https://go.drugbank.com/drugs/DB06176">DB06176</a>	L01XH02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL343448">CHEMBL343448</a>	Refractory peripheral cutaneous T-cell lymphoma	HDAC4; HDAC5; HDAC1; HDAC2; ERBB2; HDAC3; HDAC11; HDAC6; HDAC8; BRAF; KMT2A; CDKN1A; HDAC9; HDAC7; ADAMTSL4-AS1; ABCB1; CTAG1B; CDKN2D; HDAC10; BIRC5	2024-02-07	
Rucaparib	Y	Y	N		N	2016	N	<a href="https://go.drugbank.com/drugs/DB12332">DB12332</a>	L01XK03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1173055">CHEMBL1173055</a>	Advanced Ovarian Cancer	PALB2; CYP1A2; BRCA1; RAD51D; PARP1; ATM; CHEK2; BRCA2; RAD51B; PRKD2; FANCA; PARP3; CDK12; DYRK1A; RAD51C; ATR; ARID1A; BRIP1; CDK1; PIM1; IDH1; CYP2D6; PTEN; YES1; PARP2	2024-02-07	
Ruxolitinib	Y	Y	N		N	2011	N	<a href="https://go.drugbank.com/drugs/DB08877">DB08877</a>	L01EJ01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1789941">CHEMBL1789941</a>	Post Polycythemia Vera Myelofibrosis; Refractory Polycythemia vera	JAK2; JAK1; CSF3R; FLT3; BRAF; VHL; CYP3A4; CRLF2; SH2B3; TP53; IL7R; PLAUR; JAK3	2024-02-07	
Sacituzumab Govitecan	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB12893">DB12893</a>	L01FX17	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545262">CHEMBL3545262</a>	Metastatic Triple-negative Breast Cancer	UGT1A1; TACSTD2; TOP1	2024-02-07	
Selinexor	Y	Y	N		N	2019	N	<a href="https://go.drugbank.com/drugs/DB11942">DB11942</a>	L01XX66	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545185">CHEMBL3545185</a>	Refractory Multiple Myeloma	XPO1; TET2; TP53; FLT3	2024-02-07	
Selpercatinib	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB15685">DB15685</a>	L01EX22	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4559134">CHEMBL4559134</a>	Advanced RET-fusion thyroid cancer; Advanced RET-mutant medullary thyroid cancer; Metastatic RET-fusion Non Small Cell Lung Cancer; Metastatic RET-fusion thyroid cancer; Metastatic RET-mutant medullary thyroid cancer	RET; KIF5B; CCDC6	2024-02-07	
Sipuleucel-T	N	Y	N		N	2010	N	<a href="https://go.drugbank.com/drugs/DB06688">DB06688</a>	L03AX17	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1237024">CHEMBL1237024</a>	Asymptomatic, metastatic hormone-refractory Prostate cancer; Minimally symptomatic, metastatic hormone-refractory Prostate cancer	ACP3	2024-02-07	
Sonidegib	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB09143">DB09143</a>	L01XJ02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105737">CHEMBL2105737</a>	Refractory, locally advanced Basal cell carcinoma	SMO; SUFU; MYCN; FLT3; PTCH1	2024-02-07	
Sorafenib	Y	Y	N		N	2005	Y	<a href="https://go.drugbank.com/drugs/DB00398">DB00398</a>	L01EX02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1336">CHEMBL1336</a>	Advanced Renal Cell Carcinoma; Gastrointestinal Stromal Tumors; Hemangiosarcoma; Unresectable Hepatocellular Carcinoma; Locally recurrent refractory to radioactive iodine treatment Thyroid carcinoma; Metastatic refractory to radioactive iodine treatment Thyroid carcinoma	FLT1; JAK3; ARAF; DYRK3; RAF1; AURKB; PTPN6; RET; CYP2C9; SLC15A2; CDK8; VHL; HIF1A; NTRK2; ARID1A; PDGFRB; SLK; MAP2K1; BRAF; FGFR3; KRAS; YES1; IRAK1; NTRK1; PDGFRA; MAPK9; FGFR1; PIK3CA; MAPK13; MAPK12; NRAS; FLT4; EGFR; NTSR1; PLK4; KIT; UGT1A1; MAPK10; ZHX2; VEGFA; CSF1R; VEGFB; RPS6KB1; MAPK11; NF1; SRPK1; CYP3A4; MKNK2; AR; LYN; UGT1A9; IDH2; HMOX1; GMNN; MAPK7; HIPK4; MINK1; AXL; SLC22A1; ABCB1; ABCC2; ABCG2; AURKA; CYP2C8; BLK; MC4R; CYP2B6; SLCO1B1; TAOK1; CTNNB1; HIPK2; TNF; PTEN; LIMK1; CAMK2B; MAPK4; CBL; PAX8; MAPK8; MAP3K20; NTRK3; TP53; KDR; FGF3; NOS3; MAPK14; EPHA2; ABL1; MAPK6; FLT3; VEGFC; MAPK1; MAPK3; ATXN2; MAP4K5; NFE2L2	2024-02-07	
Sotorasib	Y	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB15569">DB15569</a>	L01XX73	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4535757">CHEMBL4535757</a>	Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer	KRAS	2024-02-07	
Streptozocin	N	Y	N		N	2005	N	<a href="https://go.drugbank.com/drugs/DB00428">DB00428</a>	L01AD04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1651906">CHEMBL1651906</a>	Stage 4 islet cell carcinoma	CTSD; KCNA2; MMP2; PRKAA1; GALP; BCL2; IGFBP1; PTGER4; HP; HRAS; CSF2; SI; PREP; VWF; MT1H; OGA; SST; CYP7B1; SFTPB; CDKN1B; THRSP; CD40; UCP1; LCAT; PIK3CA; RAMP3; TGFB1; TH; ENO2; ADCYAP1; SLC16A3; SLC5A1; S100B; NTRK1; ATF2; SSTR1; KCNJ11; DDIT3; TRPV1; SULT1A2; MYO9B; SLC2A5; SLC2A4; CYP2D6; HGF; ACP5	2024-02-07	
Sunitinib	Y	Y	N		N	2006	Y	<a href="https://go.drugbank.com/drugs/DB01268">DB01268</a>	L01EX01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL535">CHEMBL535</a>	Advanced Renal Cell Carcinoma; Soft Tissue Sarcoma (STS); Thyroid Cancers; Metastatic Pancreatic Neuroendocrine Tumors; Refractory Gastrointestinal stromal tumor; Unresectable, locally advanced Pancreatic Neuroendocrine Tumors	KDR; PDGFRB; RET; FLT3; KIT; FLT4; EWSR1; VEGFC; POR; PDGFRA; PDGFA; FGFR2; VEGFA; PDGFB; PTEN; NR1I2; CYP1A1; PTPRB; NR1I3; PDGFC; SLCO1B3; PDGFD; HIF1A; FGFR1; BAP1; NOS3; KDM5C; MKI67; CA9; HMOX1; PTPN12; VHL; CSF1R; PBRM1; FLT1; CYP3A4; CXCL8; YES1	2024-02-07	
Tafasitamab	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB15044">DB15044</a>	L01FX12	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298047">CHEMBL4298047</a>	Refractory Diffuse large B-cell lymphoma NOS; Relapsed Diffuse large B-cell lymphoma NOS	CD19	2024-02-07	
Tagraxofusp	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB14731">DB14731</a>	L01XX67	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297573">CHEMBL4297573</a>	Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)	EEF2; CSF2RB; IL3RA	2024-02-07	
Talazoparib	Y	Y	N		N	2018	N	<a href="https://go.drugbank.com/drugs/DB11760">DB11760</a>	L01XK04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137320">CHEMBL3137320</a>	Locally Advanced Breast Cancer (LABC); Metastatic Breast Cancer	BRCA2; PARP2; PARP1; BRCA1; PSMD4; ATRX; SLFN11; ERBB2; MYCN; PTEN; IDH2; CHEK2; FANCA; RAD51C; ARID1A; ATR; RAD51D; EGFR; PALB2; IDH1; ATM	2024-02-07	
Talimogene Laherparepvec	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB13896">DB13896</a>	L01XX51	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108727">CHEMBL2108727</a>	Unresectable Skin Lesion	CSF2RA; CSF2	2024-02-07	
Talquetamab	Y	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB16678">DB16678</a>	L01FX29	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594503">CHEMBL4594503</a>	Relapsed and Refractory Multiple Myeloma	CD3G; CD3E; CD3D; GPRC5D	2024-02-07	
Tamoxifen	N	Y	Y		Y	1977	Y	<a href="https://go.drugbank.com/drugs/DB00675">DB00675</a>	L02BA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL83">CHEMBL83</a>	Breast Cancer; Desmoid Tumors; Endometrial Cancer; Invasive Breast Cancer; Invasive Breast Carcinoma; Metastatic Breast Cancer; Ovarian Cancer	PGR; VDR; FMO3; ABCB1; ESR2; TP53; HEXB; ESR1; BRCA1; NR1I2; CYP2C9; MUC16; EDN1; ERBB2; PIK3CA; IDH1; NF1; CYP2B6; KLK3; CETP; ATXN2; GAPDH; CCND1; CYP19A1; COL18A1; EHMT2; LRMDA; E2F7; FMO1; KDM4A; MYOD1; ZNF423; PLD2; F5; BGLAP; TFF3; F2; GGT1; CBX1; NTRK1; UGT1A4; CYP2D6; DHFR; TYMS; TGFB1; NCOA1; RRAS2; GMNN; NCOA3; NRG1; TGM2; HSPB2; PIP; NFE2L2; CYP1A2; IGF1R; AURKA; BAZ2B; CCNA2; PLD1; CYP3A4	2024-02-07	
Tazemetostat	N	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB12887">DB12887</a>	L01XX72	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3414621">CHEMBL3414621</a>	Locally Advanced Epithelioid Sarcoma; Metastatic Epithelioid Sarcoma	SMARCB1; ARID1A; SMARCA4; EZH2; KDM6A; FLT3; ATRX	2024-02-07	
Tebentafusp	Y	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB15283">DB15283</a>	L01XX75	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297990">CHEMBL4297990</a>	Metastatic Uveal Melanoma (UM), Unresectable Uveal Melanoma	PMEL; TRBV20OR9-2; CD3G	2024-02-07	
Teclistamab	Y	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB16655">DB16655</a>	L01FX24	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594505">CHEMBL4594505</a>	Multiple Myeloma	CD3E; TNFRSF17; CD3D; CD3G	2024-02-07	
Tegafur, Gimeracil, Oteracil	Y	N	N		N	2011		<a href="https://go.drugbank.com/drugs/DB09256">DB09256</a>	L01BC03; L01BC53	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL20883">CHEMBL20883</a>	Advanced Gastric Cancer	DPYD; UMPS; EGFR; TYMS	2024-02-07	
Tegafur, Uracil	N	N	N	Japan	N			<a href="https://go.drugbank.com/drugs/DB09256">DB09256</a>	L01BC03; L01BC53	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL20883">CHEMBL20883</a>	Advanced Gastric Cancer	DPYD; UMPS; EGFR; TYMS	2024-02-07	
Temoporfin	Y	N	N		N	2001	N	<a href="https://go.drugbank.com/drugs/DB11630">DB11630</a>	L01XD05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL500576">CHEMBL500576</a>	Advanced Head and Neck Squamous Cell Carcinoma		2020-09-17	
Temozolomide	Y	Y	N		N	1999	Y	<a href="https://go.drugbank.com/drugs/DB00853">DB00853</a>	L01AX03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL810">CHEMBL810</a>	Advanced Melanoma; Glioblastomas; Primary Central Nervous System Lymphoma (PCNSL); Refractory Ewing Sarcoma; Refractory Neuroblastoma; Soft Tissue Sarcoma (STS); Advanced Neuroendocrine tumor; Refractory Anaplastic astrocytoma; Refractory, advanced Mycosis fungoides; Refractory, advanced Sezary Syndrome	ATR; HDAC4; SLFN11; TP53; MGMT; BRCA2; MYC; GSTP1; MSH6; IDH1; H2AX; PRL; ATM; CSF2; ALK; PTEN; ATRX	2024-02-07	
Temsirolimus	Y	Y	N		N	2007	Y	<a href="https://go.drugbank.com/drugs/DB06287">DB06287</a>	L01EG01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201182">CHEMBL1201182</a>	Advanced Renal Cell Carcinoma	MTOR; PTPRD; PIK3CA; BRAF; KRAS; NR1I2; NF2; PTEN; FBXW7; ABCB1; CYP3A5; CTNNB1; VHL; FKBP1A; RPTOR	2024-02-07	
Tepotinib	Y	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB15133">DB15133</a>	L01EX21	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3402762">CHEMBL3402762</a>	Metastatic Non-Small Cell Lung Cancer	ALK; EGFR; MET	2024-02-07	
Thalidomide	Y	Y	N		Y	1998	N	<a href="https://go.drugbank.com/drugs/DB01041">DB01041</a>	L04AX02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL468">CHEMBL468</a>	Multiple Myeloma (MM); Waldenstrom&#39;s Macroglobulinemia (WM); Treatment naive multiple myeloma	TNF; SULT1C4; DDB1; HGF; SPG7; NAT2; CHST3; PPARD; FGFR2; VWF; FGF2; CYP1A2; XRCC5; CTLA4; PTGS2; RPL13; F2R; NFKB1; HLA-B; VEGFA; CTNNB1; FCGR3B; SLC10A2; ABCC6; ATP7A; CYP2C19; ERCC1; CUL4A; CYP4B1; FCGR3A; RBX1; IL6R; MECOM; GSTT1; CRBN; SNORD68; ITGB2	2024-02-07	
Thioguanine	N	Y	N		N	1966	N	<a href="https://go.drugbank.com/drugs/DB00352">DB00352</a>	L01BB03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL727">CHEMBL727</a>	Acute Nonlymphocytic Leukemia; Nonlymphocytic Acute myeloid leukemia	ACHE; SLC28A3; IMPDH1; TPM3; AR; HBB; BMP7; TPMT; NUDT15; PRPS1; NAT1; GDA; NFE2L2; IMPDH2; IDH1; EHMT2; LINC00251; DOK5; PAX8; GATA3; NT5C2; HPGD; KDM4A; MGMT; MYC; GGH; XDH; ABCC4	2024-02-07	
Thiotepa	Y	Y	N		N	1959	Y	<a href="https://go.drugbank.com/drugs/DB04572">DB04572</a>	L01AC01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL671">CHEMBL671</a>	Adenocarcinoma of the Ovaries; Breast Adenocarcinoma; Papillary transitional cell carcinoma of bladder; Malignant effusion	AR; EHMT2; GSTP1; CYP2B6; TP53; VDR; HPGD; GMNN; ALDH1A1	2024-02-07	
Tisagenlecleucel	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB13881">DB13881</a>	L01XX71	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301574">CHEMBL3301574</a>	Refractory B-cell precursor acute lymphoblastic leukemia; Second or later relapsed B-cell precursor acute lymphoblastic leukemia	CD19; MS4A1	2024-02-07	
Tislelizumab	Y	N	N	China	N	2023		<a href="https://go.drugbank.com/drugs/DB14922">DB14922</a>	L01FF09	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297840">CHEMBL4297840</a>	Unresectable, Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma	PDCD1	2024-02-07	
Tisotumab Vedotin	N	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB16732">DB16732</a>	L01FX23	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297841">CHEMBL4297841</a>	Recurrent or metastatic cervical cancer	TUBB; TUBA3C; TUBB2A; TUBB4A; TUBB3; TUBA4A; TUBA1C; TUBA3E; TUBB4B; TUBB1; TUBB6; TUBA1A; F3; TUBB8; TUBB2B; TUBA1B	2024-02-07	
Tivozanib	Y	Y	N		N	2017	N	<a href="https://go.drugbank.com/drugs/DB11800">DB11800</a>	L01EK03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1289494">CHEMBL1289494</a>	Advanced Renal Cell Carcinoma; Renal Cell Adenocarcinoma	FLT1; KDR; FLT4; YES1; NRAS; BRAF	2024-02-07	
Topotecan	Y	Y	N		N	1996	Y	<a href="https://go.drugbank.com/drugs/DB01030">DB01030</a>	L01CE01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL84">CHEMBL84</a>	Acute Myeloid Leukemia (AML); Ewing&#39;s Sarcoma; Refractory Neuroblastoma; Metastatic Rhabdomyosarcoma; Recurrent, IV-B Cervical cancer; Refractory CNS lymphoma; Refractory CNS malignancy; Refractory, metastatic Ovarian cancer; Relapsed Small cell lung cancer	USP1; PIK3CA; HBB; TOP1; NFE2L2; PLK1; ABCB1; HIF1A; PAX8; IDH1; TYMS; DDO; PTEN; ABCG2; AR; TOP1MT; RB1; TP53; ALK; MUC16; BDNF; TSG101; AKT1; ATRX; KMT2A	2024-02-07	
Toremifene	Y	Y	N		N	1997	Y	<a href="https://go.drugbank.com/drugs/DB00539">DB00539</a>	L02BA02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1655">CHEMBL1655</a>	Desmoid Tumors; Metastatic Breast Cancer	AR; TGFB1; ESR2; GMNN; KDM4A; PGR; CYP3A4; CYP1B1; CYP2D6; CD80; HNF4A; ESR1; PLIN1	2024-02-07	
Toripalimab	N	Y	N		N	2023	N	<a href="https://go.drugbank.com/drugs/DB15043">DB15043</a>	L01FF13	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297843">CHEMBL4297843</a>	Metastatic and Recurrent Nasopharyngeal Carcinoma	PDCD1	2024-02-07	
Trabectedin	Y	Y	N		N	2015	N	<a href="https://go.drugbank.com/drugs/DB05109">DB05109</a>	L01CX01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL450449">CHEMBL450449</a>	Metastatic Leiomyosarcoma; Metastatic Liposarcoma; Relapsed platinum-sensitive Ovarian cancer; Unresectable Leiomyosarcoma; Unresectable Liposarcoma	ABCB1; PARP1; FGFR2; ABCC2; TP53	2024-02-07	
Trametinib	Y	Y	N		N	2013	N	<a href="https://go.drugbank.com/drugs/DB08911">DB08911</a>	L01EE01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103875">CHEMBL2103875</a>	Metastatic Melanoma; Unresectable Melanoma; Metastatic Non-small cell lung cancer with a BRAF V600E mutation; Pediatric  low-grade glioma (LGG) with a BRAF V600E mutation; Locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation	KRAS; NF1; HRAS; MAP2K2; MAP2K1; BRAF; MET; CDKN2A; CIC; VHL; KIT; ERBB3; ETV5; RB1; ETV4; EML4; ALK; ATM; MAP2K4; TP53; MAP2K5; RASA1; PIK3CA; ABL1; FGFR1; RET; RAF1; ETV1; CTNNB1; DNMT3A; G6PD; DUSP6; MAP2K3; PTEN; CSF3R; MAP2K6; ATXN1L; ARAF; NRAS; FGFR2; DDX43; MAP2K7; FLT3; PRKCH	2024-02-07	
Trastuzumab	Y	Y	N		Y	1998	N	<a href="https://go.drugbank.com/drugs/DB00072">DB00072</a>	L01FD01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201585">CHEMBL1201585</a>	Breast Cancer; Early Breast Cancer; Inflammatory Breast Cancer (IBC); Locally Advanced Breast Cancer (LABC); Metastatic Adenocarcinoma of the Gastro-Esophageal Junction; Metastatic Adenocarcinoma of the Stomach; Metastatic Breast Cancer; Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma	PGR; FCGR3A; KRAS; ANXA1; PIK3CA; ARID1A; ESR2; ERBB3; EPCAM; PPCDC; HGF; PTEN; IFNG; RNF8; ESR1; MET; FCGR2A; BIRC5; AKT2; EGFR; PIK3CG; RAD51C; HSPB2; MTHFR; ERBB2	2024-02-07	
Trastuzumab Deruxtecan	Y	Y	N		N	2019	N	<a href="https://go.drugbank.com/drugs/DB14962">DB14962</a>	L01FD04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297844">CHEMBL4297844</a>	HER2 Positive Breast Cancers	ERBB2; TOP1	2024-02-07	
Trastuzumab Emtansine	Y	Y	N		N	2013	N	<a href="https://go.drugbank.com/drugs/DB05773">DB05773</a>	L01FD03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743082">CHEMBL1743082</a>	Refractory, metastatic Non small cell lung cancer	ERBB2; TUBA1A; TUBB8; TUBA1B; TUBA1C; TUBB2B; TUBB6; TUBB4B; PIK3CA; TUBA3C; TUBB2A; TUBB1; TUBB; TUBA3E; TUBA4A; TUBB4A; TUBB3	2024-02-07	
Trastuzumab, Hyaluronidase	Y	Y	N		N	1998	N	<a href="https://go.drugbank.com/drugs/DB00072">DB00072</a>	L01XC03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201585">CHEMBL1201585</a>	Breast Cancer; Early Breast Cancer; Inflammatory Breast Cancer (IBC); Locally Advanced Breast Cancer (LABC); Metastatic Adenocarcinoma of the Gastro-Esophageal Junction; Metastatic Adenocarcinoma of the Stomach; Metastatic Breast Cancer; Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma	PGR; FCGR3A; KRAS; ANXA1; PIK3CA; ARID1A; ESR2; ERBB3; EPCAM; PPCDC; HGF; PTEN; IFNG; RNF8; ESR1; MET; FCGR2A; BIRC5; AKT2; EGFR; PIK3CG; RAD51C; HSPB2; MTHFR; ERBB2	2024-02-07	
Tremelimumab	Y	Y	N		N	2022	N	<a href="https://go.drugbank.com/drugs/DB11771">DB11771</a>	L01FX20	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108658">CHEMBL2108658</a>	Metastatic Non-Small Cell Lung Cancer, Unresectable Hepatocellular Carcinoma (HCC)	CTLA4	2024-02-07	
Tretinoin	N	Y	Y		N	1971	Y	<a href="https://go.drugbank.com/drugs/DB00755">DB00755</a>	D10AD01; L01XF01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL38">CHEMBL38</a>	FAB classification M3 Acute promyelocytic leukemia	RARG; BIRC5; ADH1C; TBP; MDK; MST1; FUS; CDKN1B; NR2C1; LIF; RARA; FLT3; CEACAM1; NOS1; ALPL; APOE; DUSP6; TGFB1; HES1; CALR; SMARCA4; RARB; BAX; VDR; NFE2L2; NRIP1; CYP2C9; MYCN; TG; BCL2; IL10; RXRB; SPP1; TGFBR3; ERVK2; GLI1; TP73; PTPRZ1; AMH; HOXD1; ITGB2; PML; PRL; CYP3A5; TPO; HAS3; SLC2A1; RARRES1; HIF1A; APOA1; IL1R1; HOXB1; CXCL8; IFNG; FAS; RB1; KLK3; PTCH1; XIAP; RPE65; NPM1; ALDH1A2; KAT2A; WT1; MYOD1; THBS1; BHLHE40; CD55; USP1; OCLN; HSPA8; RXRA; SHH; RAB40B; NR4A1; SFTPA1; RET; EGR2; P2RY2; EHMT2; SMAD2; MAPK8; RXRG; TSPYL2	2024-02-07	
Trifluridine, Tipiracil	Y	Y	N		N	1980	Y	<a href="https://go.drugbank.com/drugs/DB00432">DB00432</a>	L01BC59; S01AD02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1129">CHEMBL1129</a>	Metastatic Colorectal Cancer (MCRC)	ERBB2; SLC29A1; TP53	2024-02-07	
Triptorelin	N	Y	Y		N	2000	N	<a href="https://go.drugbank.com/drugs/DB06825">DB06825</a>	L02AE04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201334">CHEMBL1201334</a>	Advanced Prostate Cancer	STS; GNRHR	2024-02-07	
Trofosfamide	N	N	Y		N			<a href="https://go.drugbank.com/drugs/DB12902">DB12902</a>	L01AA07	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL462019">CHEMBL462019</a>	Non-Hodgkin&#39;s lymphoma	CYP2B6	2024-02-07	
Tucatinib	Y	Y	N		N	2020	N	<a href="https://go.drugbank.com/drugs/DB11652">DB11652</a>	L01EH03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989868">CHEMBL3989868</a>	Breast Cancer; Unresectable Breast Cancer	ERBB2	2024-02-07	
Umbralisib	N	Y	N		N	2021	N	<a href="https://go.drugbank.com/drugs/DB14989">DB14989</a>	L01EX25	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3948730">CHEMBL3948730</a>	B-cell Follicular Lymphoma; Marginal Zone Lymphoma (MZL)	PIK3CD; PIK3CG	2024-02-07	
Valrubicin	N	Y	N		N	1998	Y	<a href="https://go.drugbank.com/drugs/DB00385">DB00385</a>	L01DB09	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1096885">CHEMBL1096885</a>	In situ BCG-refractory Bladder carcinoma	TOP2A; AR	2024-02-07	
Vandetanib	Y	Y	N		N	2011	N	<a href="https://go.drugbank.com/drugs/DB05294">DB05294</a>	L01EX04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL24828">CHEMBL24828</a>	Metastatic Medullary Thyroid Cancer; Locally advanced Medullary thyroid cancer	BTK; EGFR; KRAS; KDR; ATM; RET; ABL1; EPHA5; EPHB4; EPHA3; TYRO3; FLT1; SRC; EPHA4; ALK; EPHB2; MAP2K1; ERBB3; LRRK2; LTK; EPHA10; MAP2K2; ROCK2; PTEN; IDH1; MAPK14; EPHB1; EPHA6; EPHA2; LCK; FLT4; MAP4K4; HTT; AURKB; MAP4K5; EPHB3; PTK6; EPHA1; GMNN; PDGFRA; ACVR1; ERBB2; PDGFRB; AXL; TEK; YES1; ERBB4; FYN; MTOR; FGFR1; EPHA7; APC; EPHB6; EPHA8	2024-02-07	
Vemurafenib	Y	Y	N		N	2011	N	<a href="https://go.drugbank.com/drugs/DB08881">DB08881</a>	L01EC01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1229517">CHEMBL1229517</a>	Metastatic Melanoma; Unresectable Melanoma; Refractory Non-small cell lung cancer	MET; MAP2K1; BRAF; PIK3CA; AKT1; CYP3A4; PTEN; AKT3; STAG3; ABCB1; RAC1; CIC; TF; YES1; MITF; MAP2K2; CYP3A; TET2; FGFR2; RB1; PREX2; ATXN1L; NF1; TP53; CDKN2A; CYP1A2; STAG2; SOX10; CBL; HRAS; CHEK2; PIK3R2; KRAS; NRAS	2024-02-07	
Venetoclax	Y	Y	N		N	2016	N	<a href="https://go.drugbank.com/drugs/DB11581">DB11581</a>	L01XX52	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137309">CHEMBL3137309</a>	Chronic Lymphocytic Leukaemia (CLL); Small Lymphocytic Lymphoma	NPM1; FLT3; IDH2; BCL2; IGH; ALK; IDH1; PTEN; KMT2A; NRAS; PIK3CA; KDM6A; ATM; ABL1; BRAF; TP53	2024-02-07	
Vinblastine	N	Y	Y		Y	1965	Y	<a href="https://go.drugbank.com/drugs/DB00570">DB00570</a>	L01CA01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL159">CHEMBL159</a>	Advanced Soft Tissue Sarcoma; Cancer, Bladder; Kaposi&#39;s sarcoma; Lymphoma, Hodgkins; Metastatic Melanoma; Non-Small Cell Lung Carcinoma (NSCLC); Advanced Alibert-Bazin syndrome; Advanced Testicular cancer; Histiocytic lymphoma; Refractory Breast cancer	TUBB8; TUBB2A; TUBB3; TUBB1; TUBA1C; TUBB6; TUBA1B; NR1I2; CGA; TUBA3C; GMNN; TUBB4A; TUBA4A; PTHLH; TUBB4B; TUBA3E; KLK3; TRH; GSTM1; TBXA2R; TUBB; ABCB4; TUBA1A; NOP2; TUBB2B; BRAF; CDKN1A; MMP2; CYP3A4; TUBA3D; NF1; ABCB1; CSF2	2024-02-07	
Vincristine	N	Y	Y		Y	1965	Y	<a href="https://go.drugbank.com/drugs/DB00541">DB00541</a>	L01CA02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL90555">CHEMBL90555</a>	Acute Lymphoblastic Leukaemia Recurrent; Acute Lymphocytic Leukemia (ALL); Choriocarcinoma; Chronic Lymphocytic Leukaemia (CLL); Ewing&#39;s Sarcoma; Hepatoblastomas; Kaposi&#39;s sarcoma; Lymphoma, Hodgkins; Multiple Myeloma (MM); Neuroblastomas; Non-Hodgkin&#39;s Lymphoma (NHL); Ovarian germ cell tumour; Pheochromocytomas; Retinoblastoma; Rhabdomyosarcomas; Small Cell Lung Cancer (SCLC); Wilms&#39; tumor; Advanced Thymoma	XDH; BCR; TUBA1C; TUBB3; BAHD1; TUBA3E; TUBA3C; COCH; TUBA4A; BMP7; CYP3A4; NOS3; FGF2; ABCC1; TUBB2A; ABCB4; CP; MRPL47; NRG1; CAPG; PIK3CA; TUBB4A; PNPLA3; CXCL12; DOK5; VWF; GATA3; SLC5A7; LINC00251; NCF4; SYNE2; TUBB4B; SMAD3; BCL2; RALBP1; TUBB6; TUBA3D; FCGR3A; AR; MTR; ABCC3; CEP72; CDKN1B; TYMS; ABCC10; ABCC2; MTHFR; TUBB1; ABL1; MYCN; ODC1; AFP; BDNF; TUBB2B; TP73; GMNN; ABCB1; SRI; ACTG1; NKAIN3; TOP2A; GSTA1; TUBB8; HSPB2; TUBB; NTF3; NR1I2; PIK3CG; TUBA1A; CYBA; TUBA1B	2024-02-07	
Vincristine Liposome	N	Y	N		N	2012	Y	<a href="https://go.drugbank.com/drugs/DB00541">DB00541</a>	L01CA02	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL501867">CHEMBL501867</a>	Acute Lymphoblastic Leukaemia Recurrent; Acute Lymphocytic Leukemia (ALL); Choriocarcinoma; Chronic Lymphocytic Leukaemia (CLL); Ewing&#39;s Sarcoma; Hepatoblastomas; Kaposi&#39;s sarcoma; Lymphoma, Hodgkins; Multiple Myeloma (MM); Neuroblastomas; Non-Hodgkin&#39;s Lymphoma (NHL); Ovarian germ cell tumour; Pheochromocytomas; Retinoblastoma; Rhabdomyosarcomas; Small Cell Lung Cancer (SCLC); Wilms&#39; tumor; Advanced Thymoma	TUBA1B; TUBB8; TUBB2A; TUBA1A; NR0B1; TUBA3E; TUBB3; TUBB1; HIF1A; TUBB2B; ALK; TUBB; TUBA1C; GMNN; TUBA3C; TUBB4A; TUBB6; TUBB4B; TUBA4A	2024-02-07	
Vindesine	N	N	Y		N	1979	N	<a href="https://go.drugbank.com/drugs/DB00309">DB00309</a>	L01CA03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL238071">CHEMBL238071</a>	Acute Lymphocytic Leukemia (ALL); Melanoma, Malignant	ABCB1; CYP3A4; TUBB; TUBB1	2024-02-07	
Vinflunine	Y	N	N		N	2009	N	<a href="https://go.drugbank.com/drugs/DB11641">DB11641</a>	L01CA05	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110725">CHEMBL2110725</a>	Transitional Cell Carcinoma of the Urothelial Tract; Metastatic Transitional Cell Carcinoma of the Urothelial Tract	TUBB2B; TUBB8; TUBA1C; TUBA1A; TUBB6; TUBA3E; TUBB2A; TUBB1; TUBA4A; TUBA1B; TUBB4A; TUBB; TUBB4B; TUBA3C; TUBB3	2024-02-07	
Vinorelbine	N	Y	Y		Y	1994	Y	<a href="https://go.drugbank.com/drugs/DB00361">DB00361</a>	L01CA04	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL553025">CHEMBL553025</a>	Advanced Non Small Cell Lung Cancer; Esophageal Cancers; Locally Advanced Non-Small Cell Lung Cancer; Metastatic Breast Cancer; Recurrent Cervical Cancer; Soft Tissue Sarcoma (STS); Recurrent, IV-B Cervical cancer	TUBB4B; TUBB3; RRM1; TUBA3D; CASP7; TUBA1A; TUBB6; TUBB2A; TUBA1C; APC; TUBA3E; TUBB4A; TUBB; SMARCA4; BAX; CSF2; TUBB2B; TUBB1; STMN1; TUBA3C; TUBB8; TUBA4A; BRCA1; XRCC1; TUB; TUBA1B	2024-02-07	
Vismodegib	Y	Y	N		N	2012	N	<a href="https://go.drugbank.com/drugs/DB08828">DB08828</a>	L01XJ01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL473417">CHEMBL473417</a>	Locally Advanced Basal Cell Carcinoma; Metastatic Basal cell carcinoma	PTCH1; SMO; SHH	2024-02-07	
Vorinostat	N	Y	N		N	2006	N	<a href="https://go.drugbank.com/drugs/DB02546">DB02546</a>	L01XH01	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL98">CHEMBL98</a>	Persistent Cutaneous T-Cell Lymphoma; Progressive Cutaneous T-cell lymphoma; Recurrent Cutaneous T-cell lymphoma	HDAC2; TUBB1; HDAC4; HDAC8; HDAC11; TUBB2A; TUBA3E; GNA11; PAX8; BIRC5; HDAC1; HDAC10; BRAF; NR0B1; HDAC6; ERBB2; BAP1; TUBB4A; TUBB; TUBB8; HDAC7; TUBA1A; NFE2L2; TUBA3C; HDAC3; TUBA1B; UGT2B17; TUBB3; PTEN; ACE; TUBA1C; TUBA3D; TUBA4A; MYC; TUBB4B; FBXW7; CFTR; TUBB2B; TUBB6; IDH1; HDAC5; HDAC9; CHD4; TP53; RB1; GMNN	2024-02-07	
Zanubrutinib	Y	Y	N		N	2019	N	<a href="https://go.drugbank.com/drugs/DB15035">DB15035</a>	L01EL03	<a href="https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3936761">CHEMBL3936761</a>	Mantle Cell Lymphoma (MCL)	BTK; TP53	2024-02-07	

